Practical aspects of hyaluronan based medical products

Practical Aspects of Hyaluronan Based Medical Products

Volumn , Issue , 2005, Pages 1-217

  Kuo, J W ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056980277     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (575)

1. Meyer, K. and Palmer, J., The polysaccharide of the vitreous humor, J. Biol. Chem., 107, 629–634 (1934).
2. Laurent, T., The biology of hyaluronan. Introduction. Ciba Found Symp., 143, 1–20 (1989).
3. Balazs, E. A., Laurent, T. C., and Jeanloz, R. W., Nomenclature of hyaluronic acid, Biochem. J. 235, 903 (1986).
4. Elson, L. A. and Morgan, W. T. J., A colorimetric method for the determination of glucosamine and chondrosamine, Biochem. J., 27, 1824–1828 (1933).
5. Kuhn, R. and Roth, H., Mikro-Bestimmung von Acetyl-, Benzoyl- und CMethylgruppen, Ber. Chem. Ges., 66, 1274–1278 (1933).
6. Meyer, K., The biological significance of hyaluronic acid and hyaluronidase, Physiol. Revs., 27, 335–359 (1947).
7. Rapport, M. M., Linker, A., and Meyer, K. The hydrolysis of hyaluronic acid by pneumococcal hyaluronidase, J. Biol. Chem., 192, 283–291 (1951).
8. Linker, A. and Meyer, K., Production of unsaturated uronides by bacterial hyaluronidases, Nature, 174, 1192–1194 (1954).
9. Rapport, M. M., Meyer, K., and Linker, A., Analysis of the products formed on hydrolysis of hyaluronic acid by testicular hyaluronidase, J. Am. Chem. Soc., 73, 2416–2420 (1951).
10. Weissman, B. and Meyer, K., The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord, J. Am. Chem. Soc., 76, 1753–1757 (1954).
11. Rapport, M. M., Weissman, B., Linker, A., and Meyer, K., Isolation of a crystalline disaccharide, hyalobiuronic acid, from hyaluronic acid, Nature, 168, 996–997 (1951).
12. Kennedy, J. F. and White, C. A., Bioactive Carbohydrates in Chemistry, Biochemistry, and Biology, Ellis Horwood, New York, 1983.
13. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), Conformational nomenclature for five and six membered ring forms of monosaccharides and their derivatives, Eur. J. Biochem., 111, 295–298 (1980).
14. Hirano, S. and Kondo, S., Molecular conformational transition of hyaluronic acid in solution, J. Biochem., 74, 861–862 (1973).
15. Dea, I. C. M., Moorhouse, R., Rees, D.A., Arnott, S., Guss, J.M., and Balazs, E.A., Hyaluronic acid: a novel, double helical molecule, Science, 179, 560–562 (1973).
16. Chakrabarti, B. and Balazs, E. A., Optical properties of hyaluronic acid, ultraviolet circular dichroism and optical rotatory dispersion. J. Mol. Biol., 78, 135–141 (1973).
17. Stone, A. L., Optical rotary dispersion of mucopolysaccharide and mucopolysaccharide-dye complex II. Ultraviolet cotton effects in the amide transition bands, Biopolymers, 7, 173–188 (1969).
18. Welti, D., Rees, D. A., and Welsh, E. J., Solution conformation of glycosaminoglycans: assignment of the 300-MHz 1H-magnetic resonance spectra of chondroitin 4-sulphate, chondroitin 6-sulphate and hyaluronate, and investigation of an alkali-induced conformation change, Eur. J. Biochem., 94, 505–514 (1979).
19. Scott, J. E., Heatley, F., and Hull, W. E., Secondary structure of hyaluronate in solution. A 1H-N.M.R. investigation at 300 and 500 MHz in [2H6]dimethyl sulphoxide solution, Biochem. J., 220, 197–205 (1984).
20. Bociek, S. M., Darke, A. H., Welti, D., and Rees, D. A., The 13C-NMR spectra of hyaluronate and chondroitin sulphates. Further evidence on an alkaliinduced conformation change, Eur. J. Biochem., 109, 447–456 (1980).
21. Heatley, F. and Scott, J. E., A water molecule participates in the secondary structure of hyaluronan, Biochem. J., 254, 489–493 (1988).
22. Scott, J. E., Cummings, C., Brass, A., and Chen, Y., Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowingelectron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer, Biochem. J., 274, 699–705 (1991).
23. Scott, J. E., Chemical morphology of hyaluronan, in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives, Laurent, T. C., Ed., Portland Press, London, 1998, pp. 7–15.
24. Morris, E. R., Rees, D. A., and Welsh, E. J., Conformation and dynamic interactions in hyaluronate solutions, J. Mol. Biol., 138, 383–400 (1980).
25. Laurent, T. C., Ryan, M., and Pletruszkiewicz, A., Fractionation of hyaluronic acid, the polydispersity of hyaluronic acid from the bovine vitreous body, Biochim. Biophys. Acta 42, 476–485 (1960).
26. Leith, M. M., Loftus, S. A., Kuo, J. W., DeVore, D. P., and Keates, E. U., Comparison of the properties of AMVISC and Healon, J. Cataract Refract. Surg., 13, 534–536 (1987).
27. Caplan, A. I., Cartilage, Sci. Am., 251, 84–87, 90–94 (1984).
28. Boas, N., Isolation of hyaluronic acid from the cock’s comb, J. Biol. Chem., 181, 573–575 (1949).
29. Sevag, M. G., Eine neue physikalische Enteiweissungsmethode zur Darstellung biologisch wirksamer Substanzen. Isolierung von Kohlenhydraten aus Huehnereweiss und Pneumococcen, Biochem. Zeitschrift, 273, 419–429 (1934).
30. Blix, G. and Snellman, O., On chondroitin sulphuric acid and hyaluronic acid, Arkiv. Kemi., 19A, 1–19 (1945).
31. Balazs, E. A., Ultrapure hyaluronic acid and the use thereof, U.S. Patent 4,141,973, (1979).
32. Swann, D. A., Studies on hyaluronic acid. I. The preparation and properties of rooster comb hyaluronic acid. Biochim. Biophys. Acta, 156, 17–30 (1968).
33. Swann, D. A., Studies on hyaluronic acid. II. The protein component(s) of rooster comb hyaluronic acid, Biochim. Biophys. Acta, 160, 96–105 (1968).
34. Scott, J. E., Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues, Meth. Biochem. Anal., 8, 145–197 (1960).
35. Forrest, E. K., Heidelberger, M., and Dawson, M. H., A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic Streptococcus, J. Biol. Chem., 118, 61–69 (1937).
36. Bracke, J. W. and Thacker, K., Hyaluronic acid from bacterial culture, U.S. Patent 4,517,295 (1985).
37. Brown, K. K., Ruiz, L. L. C., and Van De Rijn, I., Ultrapure hyaluronic acid and method of making it, U.S. Patent 4,782,046 (1988).
38. Brown, K. K., Ruiz, L. L. C., Van De Rijn, I., Greene, N. D., Trump, S. L., Wilson, C. D., and Bryant, S. A., Method for the microbiological production of nonantigenic hyaluronic acid, U.S. Patent 5,316,926 (1994).
39. Nimrod, A., Greenman, B., Kanner, D., Landsberg, M., and Beck, Y., Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus, U.S. Patent 4,780,414 (1988).
40. Nimrod, A., Greenman, B., Kanner, D., and Landsberg, M., High molecular weight sodium hyaluronate, U.S. Patent 4,784,990 (1988).
41. Weigel, P. H., Hascall, V. C., and Tammi, M., Hyaluronan synthases, J. Biol. Chem., 272, 13997–14000 (1997).
42. Spicer, A. P. and McDonald, J. A., Eukaryotic hyaluronan synthases, www.glycoforum.gr.jp/science/hyaluronan, 1998.
43. Reed, R. K. and Laurent, U. B., Turnover of hyaluronan in the microcirculation, Am. Rev. Respir. Dis., 146, S37–S39 (1992).
44. Laurent, T. C., in Chemistry and Molecular Biology of the Intercellular Matrix, Balazs, E. A., Ed., Academic Press, London, 1970, pp. 703–732.
45. Laurent, T. C., Dahl, I. M., Dahl, L. B., Engstrom-Laurent, A., Eriksson, S., Fraser, J. R., Granath, K. A., Laurent, C., Laurent, U. B., Lilja, K., The catabolic fate of hyaluronic acid, Connect. Tissue Res., 15, 33–41 (1986).
46. Fraser, J. R., Kimpton, W. G., Laurent, T. C., Cahill, R. N., and Vakakis, N., Uptake and degradation of hyaluronan in lymphatic tissue, Biochem. J., 256, 153–158 (1988).
47. Smedsrod, B., Cellular events in the uptake and degradation of hyaluronan, Adv. Drug Delivery Rev., 7, 265–278 (1991).
48. Fraser, J. R., Laurent, T. C., Engstrom-Laurent, A., and Laurent, U. G., Elimination of hyaluronic acid from the blood stream in the human, Clin. Exp. Pharmacol. Physiol., 11, 17–25 (1984).
49. Fraser, J. R. E., Brown, T. J., and Laurent, T. C., Catabolism of hyaluronan, in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives, Laurent, T. C., Ed., Portland Press, London, 1998, pp. 85–92.
50. Laurent, T. C. and Fraser, J. R. E., in Degradation of Bioactive Substances: Physiology and Pathophysiology, Henriksen, J. H., Ed., CRC Press, Boca Raton, FL, 1991, pp. 249–265.
51. De Salegui, M. and Pigman, W., The existence of an acid-active hyaluronidase in serum, Arch. Biochem. Biophys., 120, 60–67 (1967).
52. Stephens, R. W., Ghosh, P., and Taylor, T. K., The characterisation and function of the polysaccharidases of human synovial fluid in rheumatoid and osteoarthritis, Biochim. Biophys. Acta, 399, 101–112 (1975).
53. Laurent, T. C. and Fraser, J. R., Hyaluronan, FASEB J., 6, 2397–2404 (1992).
54. Comper, W. D. and Laurent, T. C., Physiological function of connective tissue polysaccharides, Physiol. Rev., 58, 255–315 (1978).
55. Toole, B., Hyaluronan-cell interactions in morphogenesis, in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives, Laurent, T. C., Ed., Portland Press, London, 1998, pp. 155–160.
56. Brecht, M., Mayer, U., Schlosser, E., and Prehm, P., Increased hyaluronate synthesis is required for fibroblast detachment and mitosis, Biochem. J., 239, 445–450 (1986).
57. Toole, B., in Cell Biology of Extracellular Matrix, Hay, E. D., Ed., Plenum, New York, 1991, pp. 305–341.
58. Goldberg, R. L. and Toole, B. P., Hyaluronate inhibition of cell proliferation, Arthritis Rheum., 30, 769–778 (1987).
59. Adzick, N. S. and Longaker, M. T., Scarless fetal healing. Therapeutic implications, Ann. Surg., 215, 3–7 (1992).
60. Tammi, M. I., Day, A. J., and Turley, E. A., Hyaluronan and homeostasis: a balancing act, J. Biol. Chem., 277, 4581–4584 (2002).
61. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C., and Seed, B., CD44 is the principal cell surface receptor for hyaluronate, Cell, 61, 1303–1313 (1990).
62. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., Cripps, V., Austen, L., Nance, D. M., and Turley, E. A., Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility, J. Cell Biol., 117, 1343–1350 (1992).
63. Entwistle, J., Hall, C. L., and Turley, E. A., HA receptors: regulators of signaling to the cytoskeleton, J. Cell Biochem., 61, 569–77 (1996).
64. Underhill, C. B., Nguyen, H. A., Shizari, M., and Culty, M., CD44 positive macrophages take up hyaluronan during lung development, Dev. Biol., 155, 324–336 (1993).
65. Kuo, J. W., Swann, D. A., and Prestwich, G. D., Chemical modification of hyaluronic acid by carbodiimides, Bioconjug. Chem., 2, 232–241 (1991).
66. Luo, Y., Kirker, K. R., and Prestwich, G. D., Crosslinked hyaluronic acid hydrogel films: new biomaterials for drug delivery, J. Control Release, 69, 169–184 (2000).
67. Balazs, E. A. and Leshchiner, A., Cross-linked gels of hyaluronic acid and products containing such gels, U.S. Patent 4,582,865 (1986).
68. Balazs, E. A., Leshchiner, A., Leshchiner, A., and Band, P., Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues, U.S. Patent 4,713,448 (1987).
69. Malson, T. and Lindqvist, B. L., Gel of crosslinked hyaluronic acid for use as a vitreous humor substitute, U.S. Patent 4,716,154 (1987).
70. Pouyani, T. and Prestwich, G. D., Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials, Bioconjug. Chem., 5, 339–347 (1994).
71. Della Valle, F. and Romeo, A., Esters of hyaluronic acid, U.S. Patent 4,851,521 (1989).
72. Hamilton, R., Fox, E. M., Acharya, R. A., and Walts, A. E., Water insoluble derivatives of hyaluronic acid, U.S. Patent 4,937,270 (1990).
73. Huang, W. J., Johns, D. B., and Kronenthal, R. L., Ionically crosslinked carboxylcontaining polysaccharides for adhesion prevention, U.S. Patent 5,532,221, lifecore (1996).
74. Pruett, R. C., Schepens, C. L., and Swann, D. A., Hyaluronic acid vitreous substitute. A six-year clinical evaluation, Arch. Ophthalmol., 97, 2325–2330 (1979).
75. Balazs, E. A. and Sweeney, D. B., in New and Controversial Aspects of Retinal Detachment, McPherson, A., Ed., Harper Row, New York, 1968, pp. 371–376.
76. Goa, K. L. and Benfield, P., Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing, Drugs, 47, 536–566 (1994).
77. Miller, D., O’Connor, P., and Williams, J., Use of Na-hyaluronate during intraocular lens implantation in rabbits, Ophthal. Surg., 8, 58–61 (1977).
78. Stegmann, R. and Miller, D., Extracapsular cataract extraction with hyaluronate sodium, Ann. Ophthalmol. 14, 813–815 (1982).
79. Miller, D. and Stegmann, R., Use of sodium hyaluronate in human IOL implantation, Ann. Ophthalmol., 13, 811–815 (1981).
80. Miller, D. and Stegmann, R., Use of Na-hyaluronate in anterior segment eye surgery, J. Am. Intraocul. Implant Soc., 6, 13–15 (1980).
81. Butler, J., Rydell, N. W., and Balazs, E. A., Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses, Acta Vet. Scand., 11, 139–155 (1970).
82. Peyron, J. G. and Balazs, E. A., Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints, Pathol. Biol. (Paris), 22, 731–736 (1974).
83. Migliore, A., Martin, L. S., Alimonti, A., Valente, C., and Tormenta, S., Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip, Osteoarthritis Cartilage, 11, 305–306 (2003).
84. Brocq, O., Tran, G., Breuil, V., Grisot, C., Flory, P., and Euller-Ziegler, L., Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients, Joint Bone Spine, 69, 388–391 (2002).
85. Lust, G., Beilman, W. T., Dueland, D. J., and Farrell, P. W., Intra-articular volume and hip joint instability in dogs with hip dysplasia, J. Bone Joint Surg. Am., 62, 576–582 (1980).
86. Itokazu, M. and Matsunaga, T., Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder, Clin. Ther., 17, 946–955 (1995).
87. Leardini, G., Perbellini, A., Franceschini, M., and Mattara, L., Intra-articular injections of hyaluronic acid in the treatment of painful shoulder, Clin. Ther., 10, 521–556 (1988).
88. Bertolami, C. N., Gay, T., Clark, G. T., Rendell, J., Shetty, V., Liu, C., and Swann, D. A., Use of sodium hyaluronate in treating temporomandibular joint disorders: a randomized, double-blind, placebo-controlled clinical trial, J. Oral Maxillofac. Surg., 51, 232–242 (1993).
89. McCain, J. P., Balazs, E. A., and de la Rua, H., Preliminary studies on the use of a viscoelastic solution in arthroscopic surgery of the temporomandibular joint, J. Oral Maxillofac. Surg., 47, 1161–1168 (1989).
90. Kopp, S., Carlsson, G. E., Haraldson, T., and Wenneberg, B., Long-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint arthritis, J. Oral Maxillofac. Surg., 45, 929–935 (1987).
91. Kopp, S., Wenneberg, B., Haraldson, T., and Carlsson, G. E., The short-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint pain and dysfunction, J. Oral Maxillofac. Surg., 43, 429–435 (1985).
92. Balazs, E. A. and Denlinger, J. L., Viscosupplementation: a new concept in the treatment of osteoarthritis, J. Rheumatol. Suppl., 39, 3–9 (1993).
93. Brandt, K. D., Smith, G. N. Jr., and Simon, L. S., Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?, Arthritis Rheum., 43, 1192–1203 (2000).
94. Aviad, A. D. and Houpt, J. B., The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?, J. Rheumatol., 21, 297–301 (1994).
95. Kawcak, C. E., Frisbie, D. D., Trotter, G. W., McIlwraith, C. W., Gillette, S. M., Powers, B. E., and Walton, R. M., Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation, Am. J. Vet. Res., 58, 1132–1140 (1997).
96. Lo, G. H., La Valley, M. P., McAlindon, T. E., and Felson, D. T., Is intra-articular (IA) hyaluronic acid (HA) efficacious in treating knee osteoarthritis (OA)? A meta-analysis, in 66th Annual Scientific Meeting of the ACR (American College of Rheumatology), 2002.
97. Lo, G., LaValley, M., McAlindon, T., and Felson, D., Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis, JAMA, 290, 3115–3121 (2003).
98. Mazières, B., Bannwarth, B., Dougados, M., and Lequesne, M., EULAR recommendations for the management of knee osteoarthritis. Report of task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials, Joint Bone Spine, 68, 231–240 (2001).
99. Diamond, M. P., Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group, Fertil. Steril., 66, 904–910 (1996).
100. Shimanuki, T., Nishimura, K., Montz, F. J., Nakamura, R. M., and diZerega, G. S., Localized prevention of postsurgical adhesion formation and reformation with oxidized regenerated cellulose, J. Biomed. Mater. Res., 21, 173–185 (1987).
101. Johns, D. B., Keyport, G. M., Hoehler, F., and diZerega, G. S., Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery, Fertil. Steril., 76, 595–604 (2001).
102. Sclafani, A. P. and Romo, T., III, Injectable fillers for facial soft tissue enhancement, Facial Plast. Surg., 16, 29–34 (2000).
103. Bergeret-Galley, C., Latouche, X., and Illouz, Y. G., The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep, Aesthetic Plast. Surg., 25, 249–255 (2001).
104. Lupton, J. R. and Alster, T. S., Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel, Dermatol. Surg., 26, 135–137 (2000).
105. Shafir, R., Amir, A., and Gur, E., Long-term complications of facial injections with Restylane (injectable hyaluronic acid), Plast. Reconstr. Surg., 106, 1215–1216 (2000).
106. Manna, F., Dentini, M., Desideri, P., De Pita, O., Mortilla, E., and Maras, B., Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform from rooster combs and Restylane from streptococcus) used for soft tissue augmentation, J. Eur. Acad. Dermatol. Venereol, 13, 183–192 (1999).
107. Duranti, F., Salti, G., Bovani, B., Calandra, M., and Rosati, M. L., Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study, Dermatol. Surg., 24, 1317–1325 (1998).
108. Sasaki, T. and Watanabe, C., Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid, Bone. 16, 9–15 (1995).
109. Gertzman, A. A. and Sunwoo, M. H., A pilot study evaluating sodium hyaluronate as a carrier for freeze-dried demineralized bone powder, Cell Tissue Banking, 2, 87–94 (2001).
110. Prato, G. P., Rotundo, R., Magnani, C., Soranzo, C., Muzzi, L., and Cairo, F., An autologous cell hyaluronic acid graft technique for gingival augmentation: a case series, J. Periodontol., 74, 262–267 (2003).
111. Weissman, B. and Meyer, K., The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord, J. Am. Chem. Soc., 76, 1753–1757 (1954).
112. Flowers, H. M. and Jeanloz, R. W., The synthesis of the repeating units of hyaluronic acid, Biochemistry, 3, 123–125 (1964).
113. Jeanloz, R. W. and Jeanloz, D. A., The degradation of hyaluronic acid by methanolysis, Biochemistry, 3, 121–122 (1964).
114. Murphy, D., Pennock, C. A., and London, K. J., Gas-liquid chromatographic measurement of glucosamine and galactosamine content of urinary glycosaminoglycans, Clin. Chim. Acta, 53, 145–152 (1974).
115. Radhakrishnamurthy, B., Dalferes, E. R. Jr., and Berenson, G. S., Determination of hexosamines by gas-liquid chromatography, Anal. Biochem., 17, 545–550 (1966).
116. Montgomery, R. and Nag, S., Periodate oxidation of hyaluronic acid, Biochim. Biophys. Acta, 74, 300–302 (1963).
117. Scott, J. E., Perodate oxidation, pKa, and conformation of hexuronic acids in polyuronides and mucopolysaccharides, Biochim. Biophys. Acta, 170, 471–473 (1968).
118. Scott, J. E. and Tigwell, M. J., The influence of the intrapolymer environment on periodate oxidation of uronic acids in polyuronides and glycosaminoglycuronans, Biochem. Soc. Trans., 3, 662–664 (1975).
119. Kennedy, J. F. and White, C. A., Bioactive Carbohydrates in Chemistry, Biochemistry, and Biology. Ellis Horwood, New York, 1983.
120. Dische, Z., A new specific color reaction of hexuronic acid, J. Biol. Chem., 167, 189–198 (1946).
121. Elson, L. A. and Morgan, W. T. J., A colorimetric method for the determination of glucosamine and chondrosamine, Biochem. J., 27, 1824–1828 (1933).
122. Blix, G., The determination of hexosamines according to Elson and Morgan, Acta Chem. Scand., 2, 467–473 (1948).
123. Morgan, W. T. J. and Elson, L. A., A colorimetric method for the determination of N-acetylglucosamine and N-acetylchondrosamine, Biochem. J., 28, 988–995 (1934).
124. Aminoff, D., Morgan, W. T. J., and Watkins, W. M., The action of dilute alkali on the N-acetylhexosamines and the specific blood-group mucoids, Biochem. J., 51, 379–389 (1952).
125. White, T., Studies in the amino-sugars. Part II. The action of dilute alkali solution on acylglucosamine, J. Chem. Soc., 428–437 (1940).
126. Reissig, J. L., Strominger, J. L., and Leloir, L. F., A modified colorimetric method for the estimation of N-acetylamino sugars, J. Biol. Chem., 217, 959–966 (1955).
127. Kuhn, R. and Krüger, R., Das Chromogen III der Morgan-Elson Reaktion, Chem. Ber., 90, 264–277 (1957).
128. Beau, J.-M., Rollin, P., and Sinay, P., Structure du chromogène I de la reaction de Morgen Elson, Carbohydr. Res., 53, 187–195 (1977).
129. Benson, R. L., Testing proposed reaction mechanisms with compounds bound to solid supports, J. Org. Chem., 40, 1647–1649 (1975).
130. Muckenschnabel, I., Bernhardt, G., Spruss, T., Dietl, B., and Buschauer, A., Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers, Cancer Lett., 131, 13–20 (1998).
131. Whistler, R. L. and BeMiller, J. B., Alkaline degradation of polysaccharides, Adv. Carbohydrate Chem. Biochem., 13, 289–329 (1958).
132. Kennedy, J. F. and White, C. A., in Comprehensive Organic Chemistry, The Synthesis and Reactions of Organic Compounds, Halslam, E., Ed., Pergamon, Oxford, 1979, Vol. 5, pp. 766–768.
133. Kuo, J. W., in Synthesis and Properties of Hyaluronic Acid Modified by Designed Carbodiimides, Department of Chemistry, State University of New York, Stony Brook, 1989, pp. 1–131.
134. Jennings, H. J., Roy, R., and Michon, F., Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis, J. Immunol., 134, 2651–2657 (1985).
135. Jennings, H. J., Roy, R., and Gamian, A., Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine, J. Immunol., 137, 1708–1713 (1986).
136. Linker, A., Meyer, K., and Hoffman, P., The production of unsaturated uronides by bacterial hyaluronidases, J. Biol. Chem., 219, 13–25 (1956).
137. Shively, J. E., Taylor, R. L., and Conrad, H. E., in The Methodology of Connective Tissue Research, Hall, D. A., Ed., Joynson-Bruvvers, Oxford, 1976.
138. Moggridge, R. C. G. and Neuberger, A., Methylglycosaminide: its structure, and the kinetics of its hydrolysis by acids, J. Chem. Soc., 745–750 (1938).
139. Inoue, Y. and Nagasawa, K., Preparation, by chemical degradation of hyaluronic acid, of a series of even- and odd-numbered oligosaccharides having a 2-acetamido-2-deoxy-glucose and a glucuronic acid residue, respectively, at the reducing end, Carbohydr. Res., 141, 99–110 (1985).
140. Rånby, B. G. and Marchessault, R. H., Inductive effects in the hydrolysis of cellulose chains. J Polymer Sci., 36, 561–564 (1959).
141. BeMiller, J. N., Acid-catalysed hydrolysis of glycosides, Adv. Carbohydrate Chem. Biochem., 22, 25–108 (1967).
142. Bochkov, A. F. and Zaikov, G. E., in Chemistry of the O-Glycosidic Bond, Pergamon, Oxford, 1979, pp. 177–201.
143. Roy, N. and Timell, T. E., The acid hydrolysis of glycosides: XI. Effect of pH on the hydrolysis of acid disaccharides, Carbohydr. Res., 7, 17–20 (1968).
144. Pigman, W. and Rizvi, S., Hyaluronic acid and the ORD reaction, Biochem. Biophys. Res. Commun., 1, 39–43 (1959).
145. Gilbert, D. L., Gerschman, R., Cohen, J., and Sherwood, W., The influence of high oxygen pressures on the viscosity of solutions of sodium desoxyribonucleic acid and of sodium alginate, J. Am. Chem. Soc., 79, 5677–5680 (1957).
146. Swann, D. A., Studies on the structure of hyaluronic acid. Characterization of the product formed when hyaluronic acid is treated with ascorbic acid, Biochem. J., 114, 819–825 (1969).
147. Cleland, R. L., Stoolmiller, A. C., Roden, L., and Laurent, T. C., Partial characterization of reaction products formed by the degradation of hyaluronic acid with ascorbic acid, Biochim. Biophys. Acta, 192, 385–394 (1969).
148. Uchiyama, H., Dobashi, Y., Ohkouchi, K., and Nagasawa, K., Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid, J. Biol. Chem., 265, 7753–7759 (1990).
149. Harris, M. J., Herp, A., and Pigman, W., Metal catalysis in the depolymerization of hyaluronic acid by autoxidant, J. Am. Chem. Soc., 94, 7570–7572 (1972).
150. Betts, W. H. and Cleland, L. G., Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid, Arthritis Rheum., 25, 1469–1476 (1982).
151. Halliwell, B., Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems? FEBS Lett., 92, 321–326 (1978).
152. McCord, J. M., Free radicals and inflammation: production of synovial fluid by superoxide dismutase, Science, 185, 529–531 (1974).
153. Wedlock, D. J., Phillips, G. O., Davies, A., Gormally, J., and Wyn-Jones, E., Depolymerization of sodium hyaluronate during freeze drying, Int. J. Biol. Macromol., 5, 186–188 (1983).
154. Tokita, Y., Oshima, K., and Okamoto, A., Degradation of hyaluronic acid during freeze drying, Polymer Degradation Stability, 55, 159–164 (1997).
155. Balazs, E. A. and Laurent, T. C., The viscosity function of hyaluronic acid as a polyelectrolyte, J. Polymer. Sci., 6, 665–668 (1951).
156. Balazs, E. A., Laurent, T. C., Howe, A. F., and Varga, L., Irradiation of mucopolysaccharides with ultraviolet light and electrons, Radiat. Res., 11, 149–164 (1959).
157. Balazs, E. A., Davies, J. V., Phillips, G. O., and Young, M. D., Transient intermediates in the radiolysis of hyaluronic acid, Radiat. Res., 31, 243–255 (1967).
158. Caputo, A., Depolymerization of hyaluronic acid by x-rays, Nature, 179, 1133–1134 (1957).
159. Lowry, K. M. and Beavers, E. M., Thermal stability of sodium hyaluronate in aqueous solution, J. Biomed. Mater. Res., 28, 1239–1244 (1994).
160. Miyazaki, T., Yomota, C., and Okada, S., Ultrasonic depolymerization of hyaluronic acid, Polymer Degradation Stability, 74, 77–85 (2001).
161. Laurent, T. C., Dahl, I. M., Dahl, L. B., Engstrom-Laurent, A., Eriksson, S., Fraser, J. R., Granath, K. A., Laurent, C., Laurent, U. B., Lilja, K., The catabolic fate of hyaluronic acid, Connect. Tissue Res., 15, 33–41 (1986).
162. Fraser, J. R., Laurent, T. C., Engstrom-Laurent, A., and Laurent, U. G., Elimination of hyaluronic acid from the blood stream in the human, Clin. Exp. Pharmacol. Physiol., 11, 17–25 (1984).
163. Underhill, C. B. and Toole, B. P., Binding of hyaluronate to the surface of cultured cells, J. Cell Biol., 82, 475–484 (1979).
164. Baxter, E., Fraser, J. R., and Harris, G. S., Fractionation and recovery of secretions of synovial cells synthesized in culture with radioactive precursors, Ann. Rheum. Dis., 32, 35–40 (1973).
165. Wilzbach, K. E., Tritium-labeling by exposure of organic compounds to tritium gas, J. Am. Chem. Soc., 79, 1013 (1957).
166. Highsmith, S. and Chipman, D. M., Preparation of tritium-labeled hyaluronic acid oligomers and their use in enzyme studies, Anal. Biochem., 61, 557–566 (1974).
167. Hook, M., Riesenfeld, J., and Lindahl, U., N-[3H]acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans, Anal. Biochem., 119, 236–245 (1982).
168. Swann, D. A., Silver, F. H., Sotman, S. L., and Hermann, H., Measurements of reducing end groups on bovine vitreous-humour hyaluronic acid by reaction with 14C cyanide, Biochem. J., 207, 409–414 (1982).
169. Orlando, P., Binaglia, L., De Feo, A., Orlando, M., Trenta, R., and Trevisi, R., An improved method for hyaluronic acid radioiodination, J. Labelled Compounds Radiopharmaceut., 36, 855–859 (1995).
170. Gustafson, S., Bjorkman, T., and Westlin, J. E., Labelling of high molecular weight hyaluronan with 125I-tyrosine: studies in vitro and in vivo in the rat, Glycoconj. J. 11, 608–613 (1994).
171. Westerberg, G., Bergstrom, M., Gustafson, S., Lindqvist, U., Sundin, A., and Langstrom, B., Labelling of polysaccharides using [11C]cyanogen bromide. In vivo and in vitro evaluation of 11C-hyaluronan uptake kinetics, Nucl. Med. Biol., 22, 251–256 (1995).
172. Orlando, M., De Sanctis, G., Giodano, C., Valle, G., La Bua, R., and Ghidoni, R., Tritium labeled hyaluronic acid derivative, J. Labelled Compounds Radiopharmaceut., 22, 961–969 (1985).
173. Dmitriev, B. A., Knirel Y. A., and Kochetkov, N. K., Selective cleavage of glycosidic linkages: studies with the model compound benzyl 2-acetamido-2-deoxy-3-O- β-D-galactopyranosyl-α-D-glucopyranoside, Carbohydr. Res., 29, 451–457 (1973).
174. Robert, L., Mednieks, M., and Winzler, R. J., Reaction of [14C]cyanide with hexosamines, acid polysaccharides, and some related compounds, Biochim. Biophys. Acta, 63, 327–333 (1962).
175. Raja, R. H., LeBoeuf, R. D., Stone, G. W., and Weigel, P. H., Preparation of alkylamine and 125I-radiolabeled derivatives of hyaluronic acid uniquely modified at the reducing end, Anal. Biochem., 139, 168–177 (1984).
176. Wong, S. S., Chemistry of Protein Conjugation and Crosslinking, CRC Press, Boca Raton, 1993.
177. Gustafson, S., Forsberg, N., McCourt, P., Wikstrom, T., Bjorkman, T., and Lilja, K., in First International Workshop on Hyaluronan in Drug Delivery, Willoughby, D. A., Ed., Royal Society of Medicine Press, Toronto, 1992, pp. 43–59.
178. de Belder, A. N. and Wik, K. O., Preparation and properties of fluoresceinlabelled hyaluronate, Carbohydr. Res., 44, 251–257 (1975).
179. Ugi, J., Isonitrile Chemistry, Academic Press, London, 1971.
180. Ogamo, A., Matsuzaki, K., Uchiyama, H., and Nagasawa, K., Preparation and properties of fluorescent glycosaminoglycuronans labeled with 5-aminofluorescein, Carbohydr. Res., 105, 69–85 (1982).
181. Luo, Y. and Prestwich, G. D., Hyaluronic acid-N-hydroxysuccinimide: a useful intermediate for bioconjugation, Bioconjug. Chem., 12, 1085–1088 (2001).
182. Pouyani, T. and Prestwich, G. D., Biotinylated hyaluronic acid: a new tool for probing hyaluronate-receptor interactions, Bioconjug. Chem., 5, 370–372 (1994).
183. Della Valle, F. and Romeo, A., Esters of hyaluronic acid, U.S. Patent 4,851,521, (1989).
184. Yu, Q. and Toole, B. P., Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissues, Biotechniques, 19, 122–124, 126–129 (1995).
185. Yang, B., Yang, B. L., and Goetinck, P. F., Biotinylated hyaluronic acid as a probe for identifying hyaluronic acid-binding proteins, Anal. Biochem., 228, 299–306 (1995).
186. Frost, G. I. and Stern, R., A microtiter-based assay for hyaluronidase activity not requiring specialized reagents, Anal. Biochem., 251, 263–269 (1997).
187. Bragg, P. D. and Hou, C., Subunit composition, function, and spatial arrangement in the Ca2- and Mg2-activated adenosine triphosphatases of Escherichia coli and Salmonella typhimurium, Arch. Biochem. Biophys., 167, 311–321 (1975).
188. Lomant, A. J. and Fairbanks, G., Chemical probes of extended biological structures: synthesis and properties of the cleavable protein crosslinking reagent [35S]dithiobis(succinimidyl propionate), J. Mol. Biol., 104, 243–261 (1976).
189. Hermanson, G. T., Bioconjugate Techniques, Academic Press, San Diego, CA, 1996, pp. 139–141.
190. Kuo, J. W., Swann, D. A., and Prestwich, G. D., Chemical modification of hyaluronic acid by carbodiimides, Bioconjug. Chem., 2, 232–241 (1991).
191. Hamilton, R., Fox, E. M., Acharya, R. A., and Walts, A. E., Water insoluble derivatives of hyaluronic acid, U.S. Patent 4,937,270 (1990).
192. Ruiz-Perez, B., Cisneros, R. L., Matsumoto, T., Miller, R. J., Vasios, G., Calias, P., and Onderdonk, A. B., Protection against lethal intra-abdominal sepsis by 1- (3-dimethylaminopropyl)-3-ethylurea, J. Infect. Dis., 188, 378–387 (2003).
193. Ruiz-Perez, B., Cisneros, R. L., Matsumoto, T., Miller, R. J., Vasios, G., Calias, P., Onderdonk, A. B., Tzianabos, A. O., Gershkovich, J., Johnson, J., Burns, J. W., and Stavesk, M., Therapeutic utility of chemically modified hyaluronan, Poster 62, Hyaluronan 2003 Conference, Cleveland, OH, 2003.
194. Vercruysse, K. P. and Prestwich, G. D., Hyaluronate derivatives in drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 15, 513–555 (1998).
195. Pouyani, T. and Prestwich, G. D., Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials, Bioconjug. Chem., 5, 339–347 (1994).
196. Luo, Y. and Prestwich, G. D., Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate, Bioconjug. Chem., 10, 755–763 (1999).
197. Luo, Y., Ziebell, M. R., and Prestwich, G. D., A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells, Biomacromolecules, 1, 208–218 (2000).
198. Balazs, E. A., Leshchiner, A., Leshchiner, A., and Band, P., Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues, U.S. Patent 4,713,448 (1987).
199. Balazs, E. A. and Leshchiner, A., Crosslinked gels of hyaluronic acid and products containing such gels, U.S. Patent 4,582,865 (1986).
200. Balazs, E. A. and Denlinger, J. L., Viscosupplementation: a new concept in the treatment of osteoarthritis, J. Rheumatol. Suppl., 39, 3–9 (1993).
201. Band, A. P., Hyaluronan derivatives: chemistry and clinical applications, in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives, Laurent, T. C., Ed., Portland Press, London, 1998, pp. 33–42.
202. Porath, J., General methods and coupling procedures, Methods Enzymol., 34, 13–30 (1974).
203. Porath, J. and Axen, R., Immobilization of enzymes to agar, agarose, and Sephadex supports, Methods Enzymol., 44, 19–45 (1976).
204. Vercruysse, K. P., Marecak, D. M., Marecek, J. F., and Prestwich, G. D., Synthesis and in vitro degradation of new polyvalent hydrazide crosslinked hydrogels of hyaluronic acid, Bioconjug. Chem., 8, 686–694 (1997).
205. Smith, P. A. S., The Curtius Reaction. Organic Reactions, Adams, R., Bachmann, W. E., Fieser, L. F., Johnsons, J. R., and Snyder, H. R., Eds., Wiley, New York, 1946, Vol. 3, pp. 366–367.
206. Lutter, L. C., Ortanderl, F., and Fasold, H., The use of a new series of cleavable protein-crosslinkers on the Escherichia coli ribosome, FEBS Lett., 48, 288–292 (1974).
207. Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., and Smith, P. J., Dendritic macromolecules: synthesis of starburst dendrimers, Macromolecules, 19, 2466–2468 (1986).
208. Luo, Y., Kirker, K. R., and Prestwich, G. D., Crosslinked hyaluronic acid hydrogel films: new biomaterials for drug delivery, J. Control Release, 69, 169–184 (2000).
209. de Belder, A. N. and Malson, T., Means for preventing such adhesion, and process for producing said means, U.S. Patent 4,886,787, (1989).
210. Laurent, T., Hellsing, K., and Gelotte, B., Crosslinked gels of hyaluronic acid, Acta Chem. Scand., 18, 274–275 (1964).
211. Agerup, B., Polysaccharide gel composition, U.S. Patent 5,827,937 (1998).
212. Kurzer, F. and Douraghi-Zadeh, K., Advances in the chemistry of carbodiimides, Chem. Rev., 67, 107–152 (1967).
213. Mukaiyama, T., Usui, M., Shimada, E., and Saigo, K., A convenient method for the synthesis of carboxylic esters, Chem. Lett., 1045–1048 (1975).
214. Saigo, K., Usui, M., Kikuchi, K., Shimada, E., and Mukaiyama, T., New method for the preparation of carboxylic esters, Bull. Chem. Soc. Japan., 50, 1863–1866 (1977).
215. Della Valle, F. and Romeo, A., Crosslinked carboxy polysaccharides, U.S. Patent 5,676,964 (1997).
216. Schmut, O. and Hofmann, H., Preparation of gels from hyaluronate solutions, Graefes Arch. Clin. Exp. Ophthalmol., 218, 311–314 (1982).
217. Balazs, E. A., Sediment volume and viscoelastic behavior of hyaluronic acid, Fed. Proc., 25, 1817–1822 (1966).
218. Malson, T. and Lindqvist, B. L., Gel of crosslinked hyaluronic acid for use as a vitreous humor substitute, U.S. Patent 4,716,154 (1987).
219. Johns, D., Rodgers, K., Donahue, W., Kiorpes, T., and di Zerega, G. S., Reduction of adhesion formation by postoperative administration of ionically crosslinked hyaluronic acid, Fertil. Steril., 68, 37–42 (1997).
220. Huang, W. J., Johns, D. B., and Kronenthal, R. L., Ionically crosslinked carboxylcontaining polysaccharides for adhesion prevention, U.S. Patent 5,532,221, Biomedical, Inc., Chaska, MN, (1996).
221. Crescenzi, V., Tomaci, M., and Francescangeli, A., New routes to hyaluronanbased networks and supramolecular assemblies, in Redefining Hyaluronan, Abatangelo, G. and Weigel, P. H., Eds., Elsevier, Amsterdam, 2000, pp. 173–180.
222. de Nooy, A. E., Capitani, D., Masci, G., and Crescenzi, V., Ionic polysaccharide hydrogels via the Passerini and Ugi multicomponent condensations: synthesis, behavior, and solid-state NMR characterization, Biomacromolecules, 1, 259–267 (2000).
223. Pouyani, T., Kuo, J.-W., Harbison, G. S., and Prestwich, G. D., Solid-state NMR of N-acylureas derived from the reaction of hyaluronic acid with isotopicallylabeled carbodiimides, J. Am. Chem. Soc., 114, 5972–5976 (1992).
224. Shu, X. Z., Liu, Y., Palumbo, F. S., Luo, Y., and Prestwich, G. D., In situ crosslinkable hyaluronan hydrogels for tissue engineering, Biomaterials, 25, 1339–1348 (2004).
225. Park, Y. D., Tirelli, N., and Hubbell, J. A., Photopolymerized hyaluronic acidbased hydrogels and interpenetrating networks, Biomaterials, 24, 893–900 (2003).
226. Shu, X. Z., Liu, Y., Palumbo, F., and Prestwich, G. D., Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth, Biomaterials, 24, 3825–3834 (2003).
227. Jia, X., Colombo, G., Padera, R., Langer, R., and Kohane, D. S., Prolongation of sciatic nerve blockade by in situ crosslinked hyaluronic acid, Biomaterials, 25, 4797–4804 (2004).
228. Lutolf, M. P., Tirelli, N., Cerritelli, S., Cavalli, L., and Hubbell, J. A., Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids, Bioconjug. Chem., 12, 1051–1056 (2001).
229. Friedman, M., Cavins, J. F., and Wall, J. S., Relative nucleophilic reactivities of amino groups and mercaptide ions in addition reactions with α, β-unsaturated compounds, J. Am. Chem. Soc., 87, 3672–3682 (1965).
230. Rapport, M. M., Meyer, K., and Linker, A., Analysis of the products formed on hydrolysis of hyaluronic acid by testicular hyaluronidase, J. Am. Chem. Soc., 73, 2416–2420 (1951).
231. Rapport, M. M., Linker, A., and Meyer, K., The hydrolysis of hyaluronic acid by pneumococcal hyaluronidase, J. Biol. Chem., 192, 283–291 (1951).
232. Linker, A. and Meyer, K., Production of unsaturated uronides by bacterial hyaluronidases, Nature, 174, 1192–1194 (1954).
233. Cabezas, J. A., Reglero, A., De Pedro, A., Diez, T., and Calvo, P., Hydrolysis of natural and synthetic substrates by alpha-L-fucosidase, beta-D-glucuronidase, and beta-N-acetylhexosaminidase purified from molluscs, Int. J. Biochem., 13, 389–393 (1981).
234. Linker, A., Meyer, K., and Hoffman, P., The production of hyaluronate oligosaccharides by leech hyaluronidase and alkali, J. Biol. Chem., 235, 924–927 (1960).
235. Nebinger, P., Koel, M., Franz, A., and Werries, E., High-performance liquid chromatographic analysis of even- and odd-numbered hyaluronate oligosaccharides, J. Chromatography, 265, 19–25 (1983).
236. West, D. C., Hampson, I. N., Arnold, F., and Kumar, S., Angiogenesis induced by degradation products of hyaluronic acid, Science, 228, 1324–1326 (1985).
237. Slevin, M., Kumar, S., and Gaffney, J., Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses, J. Biol. Chem., 277, 41046–41059 (2002).
238. Lokeshwar, V. B. and Selzer, M. G., Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells, J. Biol. Chem., 275, 27641–27649 (2000).
239. Fieber, C., Baumann, P., Vallon, R., Termeer, C., Simon, J. C., Hofmann, M., Angel, P., Herrlich, P., and Sleeman, J. P., Hyaluronan-oligosaccharide-induced transcription of metalloproteases, J. Cell Sci., 117, 359–367 (2004).
240. Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J. W., and Stamenkovic, I., Inhibition of tumor growth in vivo by hyaluronan oligomers, Int. J. Cancer, 77, 396–401 (1998).
241. Mahoney, D. L., Aplin, R. T., Calabro, A., Hascall, V. C., and Day, A. J., Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length, Glycobiology, 11, 1025–1033 (2001).
242. Tawada, A., Masa, T., Oonuki, Y., Watanabe, A., Matsuzaki, Y., and Asari, A., Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers, Glycobiology, 12, 421–426 (2002).
243. Carter, M. B., Petillo, P. A., Anderson, L., and Lerner, L. E., The 1,4-linked disaccharide of hyaluronan: synthesis of methyl 2-acetamido-2-deoxy-beta- D-glucopyranosyl-(14)-beta-D-glucopyrano sid uronic acid, Carbohydr. Res., 258, 299–306 (1994).
244. Slaghek, T. M., Nakahara, Y., Ogawa, T., Kamerling, J. P., and Vliegenthart, J. F., Synthesis of hyaluronic acid-related di-, tri-, and tetra-saccharides having an N-acetylglucosamine residue at the reducing end, Carbohydr. Res., 255, 61–85 (1994).
245. Slaghek, T. M., Hypponen, T. K., Ogawa, T., Kamerling, J. P., and Vliegenthart, J. F., Synthesis of hyaluronic acid related di- and tetra-saccharides having a glucuronic acid at the reducing end, Tetrahedron. Asym., 5, 2291–2301 (1994).
246. Blatter, G. and Jacquinet, J. C., The use of 2-deoxy-2-trichloroacetamido-Dglucopyranose derivatives in syntheses of hyaluronic acid-related tetra-, hexa-, and octa-saccharides having a methyl beta-D-glucopyranosiduronic acid at the reducing end, Carbohydr. Res., 288, 109–125 (1996).
247. Adamski-Werner, S. L., Yeung, B. K., Miller-Deist, L. A., and Petillo, P. A., Gramscale syntheses of the (13)-linked and (14)-linked hyaluronan disaccharides, Carbohydr. Res., 339, 1255–1262 (2004).
248. Plante, O. J., Palmacci, E. R., and Seeberger, P. H., Automated solid-phase synthesis of oligosaccharides, Science, 291, 1523–1527 (2001).
249. Palmacci, E. R., Plante, O. J., Hewitt, M. C., and Seeberger, P. H., Automated synthesis of oligosaccharides, Helvetica Chim. Acta, 86, 3975–3990 (2003).
250. Palmacci, E. R. and Seeberger, P. H., Toward the modular synthesis of glycosaminoglycans: synthesis of hyaluronic acid disaccharide building blocks using a periodic acid oxidation, Tetrahedron, 60, 7755–7766 (2004).
251. De Luca, C., Lansing, M., Martini, I., Crescenzi, F., Shen, G.-J., O’Regan, M., and Wong, C.-H. Enzymic synthesis of hyaluronic acid with regeneration of sugar nucleotides, J. Am. Chem. Soc., 117, 5869–5870 (1995).
252. DeAngelis, P. L., Microbial glycosaminoglycan glycosyltransferases, Glycobiology, 12, 9R–16R (2002).
253. DeAngelis, P. L., Oatman, L. C., and Gay, D. F., Rapid chemoenzymatic synthesis of monodisperse hyaluronan oligosaccharides with immobilized enzyme reactors, J. Biol. Chem., 278, 35199–25203 (2003).
254. DeAngelis, P. L., Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses, Cell Mol. Life Sci., 56, 670–682 (1999).
255. Jing, W. and DeAngelis, P. L., Dissection of the two transferase activities of the Pasteurella multocida hyaluronan synthase: two active sites exist in one polypeptide, Glycobiology, 10, 883–889 (2000).
256. Balazs, E. A., Hogberg, B., and Laurent, T., Biological activity of hyaluron sulfuric acid, Acta Physiol. Scand., 23, 168–178 (1951).
257. Chang, N., Intrieri, C., Mattison, J., and Armand, G., Synthetic polysulfated hyaluronic acid is a potent inhibitor for tumor necrosis factor production, J. Leukoc. Biol., 55(6), 778–784 (1994).
258. Whistler, R. L. and Spencer, W., in Sulfation by Triethylamine-Sulfur Trioxide Complex in Methods in Carbohydrate Chemistry, Whistler, R. L., Ed., Academic Press, New York, 1964, pp. 297–298.
259. Phillips, G. B. and O’Neill, M., Sterilization (Chapter 78) in Remington's Pharmaceutical Sciences, Gennaro, A. R., Ed., Mack Publishing Company, Easton, Pennsylvania, 1990, pp. 1470–1480.
260. Fouissac, E., Milas, M., Rinaudo, M., and Borsali, R., Influence of the ionic strength on the dimensions of sodium hyaluronate, Macromolecules, 25, 5613–5617 (1992).
261. Fouissac, E., Milas, M., and Rinaudo, M., Shear-rate, concentration, molecular weight, and temperature viscosity dependences of hyaluronate, a wormlike polyelectrolyte, Macromolecules, 26, 6945–6951 (1993).
262. Gomez, J. E. and Thurston, G. B., Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids, Biorheology, 30, 409–427 (1993).
263. Mo, Y. and Nishinari, K., Rheology of hyaluronan solutions under extensional flow, Biorheology, 38, 379–387 (2001).
264. Yanaki, T. and Yamaguchi, T., Temporary network formation of hyaluronate under a physiological condition. 1. Molecular-weight dependence, Biopolymers, 30, 415–425 (1990).
265. Reed, W. F., Reed, C. E., and Byers, L. D., Random coil scission rates determined by time-dependent total intensity light scattering: hyaluronate depolymerization by hyaluronidase, Biopolymers, 30, 1073–1082 (1990).
266. Cleland, R. L., Ionic polysaccharides. II. Comparison of polyelectrolyte behavior of hyaluronate with that of carboxymethyl cellulose, Biopolymers, 6, 1519–1529 (1968).
267. Cleland, R. L., Ionic polysaccharides. IV. Free-rotation dimensions for disaccharide polymers. Comparison with experiment for hyaluronic acid, Biopolymers, 9, 811–824 (1970).
268. Cleland, R. L., Viscometric study of the proteoglycan–hyaluronate (2:1) “dimer”: minimum hyaluronate chain length, Biopolymers, 22, 2501–2056 (1983).
269. Cleland, R. L. and Wang, J. L., Ionic polysaccharides. 3. Dilute solution properties of hyaluronic acid fractions, Biopolymers, 9, 799–810 (1970).
270. Gibbs, D. A., Merrill, E. W., Smith, K. A., and Balazs, E., Rheology of hyaluronic acid, Biopolymers, 6, 777–791 (1968).
271. Kinsinger, J. B., in Encyclopedia of Polymer Science and Technology, Mark, H. F. G., and Gaylord, N. G., Eds., Interscience, New York, 1971, Vol. 14, pp. 717–740.
272. Billmeyer Jr., F. W., Synthetic Polymers — Building the Giant Molecule, Doubleday, Garden City, NY, 1972.
273. Morris, E. R., Rees, D. A., and Welsh, E. J., Conformation and dynamic interactions in hyaluronate solutions, J. Mol. Biol., 138, 383–400 (1980).
274. Kurata, M., Tsunashima, Y., Iwama, M., and Kamada, K., in Polymer Handbook, Brandup, J., Immergutt, E. H., and McDowell, W., Eds., Wiley, New York, 1975, Vol. 4, pp. 30–33.
275. Goodall, D. M., Polysaccharide conformations and kinetics, Acc. Chem. Res., 20, 59–65 (1987).
276. Rees, D. A., Polysaccharide conformation (Chapter 8), in Carbohydrates, MTP Int. Rew. Sci., Organic Chemistry, Series One, Aspinall, G. O., Ed., Butterworths, London, 1973, Vol. 7, pp. 251–283.
277. Rees, D. A., Polysaccharides: conformational properties in solution, 26.4, in Comprehensive Organic Chemistry, Barton, D. and Ollis, W. D., Eds., Fergamon, Oxford, 1979, Vol. 5, pp. 817–830.
278. Rees, D. A. and Scott, W. E., Polysaccharide conformation. Part VI. Computer model-building for linear and branched pyranoglycans. Correlations with biological function. Prelimimary assessment of inter-residue forces in aqueous solution. Further interpretation of optical rotation in terms of chain conformation, J. Chem. Soc. (B), 469–479 (1971).
279. Rees, D. A. and Welsh, E. J., Secondary and tertiary structure of polysaccharides in solutions and gels, Angew. Chem. Int. Ed. Engl., 16, 214–224 (1977).
280. Laurent, T. C., Ryan, M., and Pletruszkiewicz, A. Fractionation of hyaluronic acid, The polydispersity of hyaluronic acid from the bovine vitreous body. Biochim. Biophys. Acta, 42, 476–485 (1960).
281. Ueno, Y., Tanaka, Y., Horie, K., and Tokuyasu, K., Low-angle laser light scattering measurements on highly purified sodium hyaluronate from rooster comb, Chem. Pharm. Bull., 12, 4971–4975 (1988).
282. Phelps, C. F., The dilute solution properties of glycosaminoglycans and proteoglycans, (Chapter 2), in Molecular Biophysics of the Extracellular Matrix, Arnott, S., Rees, D. A., and Morris, E. R., Eds., Humana, Clifton, NJ, 1983, pp. 21–39.
283. Cleland, R. L., Viscometry and sedimentation equilibrium of partially hydrolyzed hyaluronate: comparison with theoretical models of wormlike chains, Biopolymers, 23, 647–666 (1984).
284. Shimada, E. and Matsumura, G., Viscosity and molecular weight of hyaluronic acid, J. Biochem., 78, 513 (1975).
285. Bothner, H., Waaler, T., and Wik, O., Limiting viscosity number and weight average molecular weight of hyaluronate samples produced by heat degradation, Int. J. Biol. Macromol., 10, 287–291 (1988).
286. Turner, R. E., Lin, P., and Cowman, M. K., Self-association of hyaluronate segments in aqueous NaCl solution, Arch. Biochem. Biophys., 265, 484–495 (1988).
287. Molyneux, P., in Water-Soluble Synthetic Polymers: Properties and Behavior, CRC Press, Boca Raton, FL, 1985.
288. Morris, E. R., Rees, D. A., Welsh, E. J., Dunfield, L. G., and Whittington, S. G., Relation between primary structure and chain flexibility of random coil polysaccharides: calculation and experiment for a range of model carrageenans, J. Chem. Soc. Trans. Perkin II, 7, 793–800 (1978).
289. Arnott, S. and Mitra, A. K., X-ray diffraction analyses of glycosaminoglycans (Chapter 3), in Molecular Biophysics of the Extracellular Matrix, Arnott, S., Rees, D. A., and Morris, E. R., Eds., Humana, Clifton, NJ, 1983, pp. 41–67.
290. Guss, J. M., Hukins, D. W., Smith, P. J., Winter, W. T., and Arnott, S., Hyaluronic acid: molecular conformations and interactions in two sodium salts, J. Mol. Biol., 95, 359–384 (1975).
291. Mitra, A. K., Raghunathan, S., Sheehan, J. K., and Arnott, S., Hyaluronic acid: molecular conformations and interactions in the orthorhombic and tetragonal forms containing sinuous chains, J. Mol. Biol., 169, 829–859 (1983).
292. Mitra, A. K., Arnott, S., and Sheehan, J. K., Hyaluronic acid: molecular conformation and interactions in the tetragonal form of the potassium salt containing extended chains, J. Mol. Biol., 169, 813–827 (1983).
293. Sheehan, J. K., Gardner, K. H., and Atkins, E. D., Hyaluronic acid: a doublehelical structure in the presence of potassium at low pH and found also with the cations ammonium, rubidium, and caesium, J. Mol. Biol., 117, 113–135 (1977).
294. Arshinoff, S. A. and Hofman, I., Prospective, randomized trial comparing Micro Visc Plus and Healon GV in routine phacoemulsification, J. Cataract Refract. Surg., 24, 814–820 (1998).
295. Bothner, H. and Wik, O., Rheology of hyaluronate, Acta Otolaryngol. Suppl., 442, 25–30 (1987).
296. Yanaki, T. and Yamaguchi, M., Shear-rate dependence of the intrinsic viscosity of sodium hyaluronate in 0.2 M sodium chloride solution, Chem. Pharm. Bull., 42, 1651–1654 (1994).
297. Arshinoff, S. A., Dispersive and cohesive viscoelastic materials in phacoemulsification revisited 1998, Ophthal. Pract., 16, 24–32 (1998).
298. Leith, M. M., Loftus, S. A., Kuo, J. W., DeVore, D. P., and Keates, E. U., Comparison of the properties of AMVISC and Healon, J. Cataract Refract. Surg., 13, 534–536 (1987).
299. Welsh, E. J., Rees, D. A., Morris, E. R., and Madden, J. K., Competitive inhibition evidence for specific intermolecular interactions in hyaluronate solutions, J. Mol. Biol., 138, 375–382 (1980).
300. DeVore, D. P. and Loftus, S. A., Rheology of sodium hyaluronate solutions and relevance to their use as medical implant, Mat. Res. Soc. Symp. Proc., 110, 455–461 (1989).
301. Ogston, A. G. and Stanier, J. E., Elastic properties of ox synovial fluid, Nature, 165, 571 (1950).
302. Ogston, A. G. and Stanier, J. E., The physiological function of hyaluronic acid in synovial fluid: viscous, elastic, and lubricant properties, J. Physiol., 119, 244–252 (1953).
303. Balazs, E. A. and Delinger, J. L., Sodium hyaluronate and joint function, J. Equine Vet. Sci., 5, 217–228 (1985).
304. Wik, H. B. and Wik, O., Rheology of hyaluronan, in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives, Portland, London, 1998, pp. 25–32.
305. Sodium Hyaluronate Natrii hyalurona, in European Pharmacopoeia Supplement, pp 1190–1193, European Directorate for the Quality of Medicines of the Council of Europe, Strasbourg, 2000.
306. Ophthalmic Implants — Ophthalmic Viscosurgical Devices, ISO 15798 (2001).
307. Arshinoff, S. A., New terminology: ophthalmic viscosurgical devices, J. Cataract Refract. Surg., 26, 627–628 (2000).
308. Dick, H. B., Augustin, A. J., and Pfeiffer, N., Osmolality of various viscoelastic substances: comparative study, J. Cataract Refract. Surg., 26, 1242–6 (2000).
309. Dick, H. B., Augustin, A. J., Pakula, T., and Pfeiffer, N., Endotoxins in ophthalmic viscosurgical devices, Eur. J. Ophthalmol., 13, 176–184 (2003).
310. Torngren, L., Lundgren, B., and Madsen, K., Intraocular pressure development in the rabbit eye after aqueous exchange with ophthalmic viscosurgical devices, J. Cataract Refract. Surg., 26, 1247–1252 (2000).
311. Magnusson, B. and Kligman, A. M., The identification of contact allergens by animal assay. The guinea pig maximization test, J. Invest. Dermatol., 52, 268–276 (1969).
312. Ames, B. N., McCann, J., and Yamasaki, E., Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutat. Res., 31, 347–364 (1975).
313. Galloway, S. M., Bloom, A. D., Resnick, M., Margolin, B. H., Nakamura, F., Archer, P., and Zeiger, E., Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: comparison of results for 22 compounds in two laboratories, Environ. Mutagen, 7, 1–51 (1985).
314. Orr, S. F. D., Infra-red spectroscopic studies of some polysaccharides, Biochim. Biophys. Acta, 14, 173–181 (1954).
315. Cael, J. J., Isaac, D. H., Blackwell, J., and Koenig, J. L., Polarized infrared spectra of crystalline glycosaminoglycans, Carbohydr. Res., 50, 169–179 (1976).
316. Atkins, E. D., Phelps, C. F., and Sheehan, J. K., The conformation of the mucopolysaccharides, hyaluronates, Biochem. J., 128, 1255–1263 (1972).
317. Guss, J. M., Hukins, D. W., Smith, P. J., Winter, W. T., and Arnott, S., Hyaluronic acid: molecular conformations and interactions in two sodium salts, J. Mol. Biol., 95, 359–84 (1975).
318. Mitra, A. K., Raghunathan, S., Sheehan, J. K., and Arnott, S., Hyaluronic acid: molecular conformations and interactions in the orthorhombic and tetragonal forms containing sinuous chains, J. Mol. Biol., 169, 829–59 (1983).
319. Gilli, R., Kacurakova, M., Mathlouthi, M., Navarini, L., and Paoletti, S., FTIR studies of sodium hyaluronate and its oligomers in the amorphous solid phase and in aqueous solution, Carbohydr. Res., 263, 315–326 (1994).
320. Bitter, T. and Muir, H. M., A modified uronic acid carbazole reaction, Anal. Biochem., 4, 330–334 (1962).
321. Gold, E. W., A simple spectrphotometric method for estimating glycosaminoglycan concentrations, Anal. Biochem., 99, 183–188 (1979).
322. Morgan, W. T. J. and Elson, L. A., A colorimetric method for the determination of N-acetylglucosamine and N-acetylchondrosamine, Biochem. J., 28, 988–995 (1934).
323. Aminoff, D., Morgan, W. T. J., and Watkins, W. M., The action of dilute alkali on the N-acetylhexosamines and the specific blood-group mucoids, Biochem J., 51, 379–389 (1952).
324. Reissig, J. L., Strominger, J. L., and Leloir, L. F., A Modified colorimetric methods for the estimation of N-acetylamino sugars, J. Biol. Chem., 217, 959–966 (1955).
325. Asteriou, T., Deschrevel, B., Delpech, B., Bertrand, P., Bultelle, F., Merai, C., and Vincent, J. C., An improved assay for the N-acetyl-D-glucosamine reducing ends of polysaccharides in the presence of proteins, Anal. Biochem., 293, 53–59 (2001).
326. Jourdian, G. W., Wolfman, M., Sarber, R., and Distier, J., A specific, sensitive method for the determination of hyaluronate, Anal. Biochem., 96, 474–480 (1979).
327. Hascall, V. C., Riolo, R. L., Hayward Jr. J., and Reynolds, C. C., Treatment of bovine nasal cartilage proteoglycan with chondroitinases from Flavobacterium heparinum and Proteus vulgaris, J. Biol. Chem., 247, 4521–4528 (1972).
328. Adams, M. E. and Muir, H., An automated version of the periodate-thiobarbituric acid assay for analysis of ^-4,5 unsaturated uronic acids and its application to the assay of hyaluronic acids and chondroitin sulfates, Anal. Biochem., 109, 426–431 (1980).
329. Li, X. Q., Thonar, E. J. M. A., and Knudson, W., Accumulation of hyaluronate in human lung carcinomam as measured by a new hyaluronate ELISA, Connect Tissue Res., 19, 243–254 (1989).
330. Chichibu, K., Matsuura, T., Shichijo, S., and Yokoyama, M. M., Assay of serum hyaluroic acid in clinical application, Clin. Chim. Acta, 181, 317–324 (1989).
331. Delpech, B., Bertrand, P., and Maingonnat, C., Immunoenzymoassay of the hyaluronic acid-hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients, Anal. Biochem., 149, 555–565 (1985).
332. Goldberg, R. L., Enzyme-linked immunosorbent assay for hyaluronate using cartilage proteoglycan and an antibody to keratan sulfate, Anal. Biochem., 174, 448–58 (1988).
333. Lindqvist, U., Chichibu, K., Delpech, B., Goldberg, R. L., Knudson, W., Poole, A. R., and Laurent, T.C., Seven different assays of hyaluronan compared for clinical utility, Clin. Chem., 38, 127–132 (1992).
334. Chichibu, K., Method of assaying high molecular hyaluronic acid and kit of reagents for such assay, U.S. Patent 5,019, 498, (1991).
335. Hyaluronic Acid (HA) Quantitative Test Kit, for Investigational Use Only, Corgenix, Inc., Westminster, Co. http://www.corgenix.com, (2001).
336. Takei, Y. G., Honma, T., and Ito, A., Quantitation of hyaluronic acid in serum with automated microparticle photometric agglutination assay, J. Immunoassay Immunochem., 23, 85–94 (2002).
337. Welti, D., Rees, D. A., and Welsh, E. J., Solution conformation of glycosaminoglycans: assignment of the 300-MHz 1H-magnetic resonance spectra of chondroitin 4-sulphate, chondroitin 6-sulphate, and hyaluronate, and investigation of an alkali-induced conformation change, Eur. J. Biochem., 94, 505–514 (1979).
338. Scott, J. E., Heatley, F., and Hull, W. E., Secondary structure of hyaluronate in solution. A 1H-N.M.R. investigation at 300 and 500 MHz in [2H6]dimethyl sulphoxide solution, Biochem. J., 220, 197–205 (1984).
339. Heatley, F. and Scott, J. E., A water molecule participates in the secondary structure of hyaluronan, Biochem. J., 254, 489–493 (1988).
340. Cowman, M. K., Cozart, D., Nakanishi, K., and Balazs, E. A., 1H NMR of glycosaminoglycans and hyaluronic acid oligosaccharides in aqueous solution: the amide proton environment, Arch. Biochem. Biophys., 230, 203–212 (1984).
341. Kuo, J. W., Swann, D. A., and Prestwich, G. D., Chemical modification of hyaluronic acid by carbodiimides, Bioconjug. Chem., 2, 232–241 (1991).
342. Kuo, J. W., in Synthesis and Properties of Hyaluronic Acid Modified by Designed Carbodiimides, Department of Chemistry, State University of New York, Stony Brook, 1989, pp. 1–131.
343. Pouyani, T., Kuo, J.-W., Harbison, G. S., and Prestwich, G. D., Solid-state NMR of N-acylureas derived from the reaction of hyaluronic acid with isotopicallylabeled carbodiimides, J. Am. Chem. Soc., 114, 5972–5976 (1992).
344. de Nooy, A. E., Capitani, D., Masci, G., and Crescenzi, V., Ionic polysaccharide hydrogels via the Passerini and Ugi multicomponent condensations: synthesis, behavior and solid-state NMR characterization, Biomacromolecules, 1, 259–267 (2000).
345. Price, K. N., Tuinman, A., Baker, D. C., Chisena, C., and Cysyk, R. L., Isolation and characterization by electrospray-ionization mass spectrometry and highperformance anion-exchange chromatography of oligosaccharides derived from hyaluronic acid by hyaluronate lyase digestion: observation of some heretofore unobserved oligosaccharides that contain an odd number of units, Carbohydr. Res., 303, 303–311 (1997).
346. Yeung, B. and Marecak, D., Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionization mass spectrometry, J. Chromatography, 852, 573–581 (1999).
347. Mahoney, D. L., Aplin, R. T., Calabro, A., Hascall, V. C., and Day, A. J., Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length, Glycobiology, 11, 1025–1033 (2001).
348. Tawada, A., Masa, T., Oonuki, Y., Watanabe, A., Matsuzaki, Y., and Asari, A., Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers, Glycobiology, 12, 421–426 (2002).
349. Christiansen, J. A. and Jensen, C. E., An inverted microosmometer and its use for the determination of molecular weight of some specimens of potassium hyaluronate, Acta Chem. Scand., 7, 1247–54 (1953).
350. Lapcik, L., Jr., Lapcik, L., De Smedt, S., Demeester, J., and Chabrecek, P., Hyaluronan: preparation, structure, properties, and applications, Chem. Rev., 98, 2663–2684 (1998).
351. Hokputsa, S., Jumel, K., Alexander, C., and Harding, S. E., A comparison of molecular mass determination of hyaluronic acid using SEC/MALLS and sedimentation equilibrium, Eur. Biophys. J., 32, 450–456 (2003).
352. Laurent, T. C., Ryan, M., and Pletruszkiewicz, A., Fractionation of hyaluronic acid, the polydispersity of hyaluronic acid from the bovine vitreous body, Biochim. Biophys. Acta., 42, 476–485 (1960).
353. Ueno, Y., Tanaka, Y., Horie, K., and Tokuyasu, K., Low-angle laser light scattering measurements on highly purified sodium hyaluronate from rooster comb, Chem. Pharm. Bull., 12, 4971–4975 (1988).
354. Laurent, T. C. and Gergely, J., Light scattering studies on hyaluronic acid, J. Biol. Chem., 212, 325–333 (1955).
355. Soltes, L., Mendichi, R., Lath, D., Mach, M., and Bakos, D., Molecular characteristics of some commercial high-molecular-weight hyaluronans, Biomed. Chromatogr., 16, 459–462 (2002).
356. Laurent, T. C., Studies on hyaluronic acid in the vitreous body, J. Biol. Chem., 216, 263–271 (1955).
357. Della Valle, F. and Romeo, A., Esters of hyaluronic acid, U.S. Patent 4,851,521, (1989).
358. Luo, Y. and Prestwich, G. D., Hyaluronic acid-N-hydroxysuccinimide: a useful intermediate for bioconjugation, Bioconjug. Chem., 12, 1085–1088 (2001).
359. Berman, E. R., Isolation of bovine vitreous hyaluronic acid on diethylaminoethylsephadex, Biochim. Biophys. Acta, 58, 120–122 (1962).
360. Swann, D. A., Studies on hyaluronic acid. I. The preparation and properties of rooster comb hyaluronic acid, Biochim. Biophys. Acta, 156, 17–30 (1968).
361. Nebinger, P., Comparison of gel permeation and ion-exchange chromatographic procedures for the separation of hyaluronate oligosaccharides, J. Chromatography, 320, 351–359 (1985).
362. Zhang, Y., Inoue, Y., Inoue, S., and Lee, Y. C., Separation of oligo/polymers of 5-N-acetylneuraminic acid, 5-N-glycolylneuraminic acid, and 2-Keto-3-deoxyglycero- galacto-nononic acid by high-performance anion-exchange chromatography with pulsed amperometric detector, Anal. Biochem., 250, 245–251 (1997).
363. Karlsson, G. and Bergman, R., Determination of the distribution of molecular masses of hyaluronate by high-performance anion-exchange chromatography, J. Chromatography A, 986, 67–72 (2003).
364. Skoog, D. A., Principles of Instrumental Analysis, Sanders College Publishing, Philadelphia, PA, 1985.
365. Miyazaki, T., Yomota, C., and Okada, S., Ultrasonic depolymerization of hyaluronic acid, Polymer Degradation Stabil., 74, 77–85 (2001).
366. Terbojevich, M., Cosani, A., and Palumbo, M., Molecular weight distribution of hyaluronic acid by high-performance gel-permeation chromatography, Carbohydr. Res., 157, 269–272 (1986).
367. Lee, H. G. and Cowman, M. K., An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution, Anal. Biochem., 219, 278–287 (1994).
368. Nakano, T., Nakano, K., and Sim, J. S., A simple rapid method to estimate hyaluronic acid concentrations in rooster comb and wattle using cellulose acetate electrophoresis, J. Agric. Food Chem., 42, 2766–2768 (1994).
369. Platzer, M., Ozegowski, J. H., and Neubert, R. H. H., Quantification of hyaluronan in pharmaceutical formulations using high performance capillary electrophoresis and the modified uronic acid carbazole reaction, J. Pharm. Biomed. Anal., 21, 491–496 (1999).
370. Grimshaw, J., Kane, A., Douglas, A., Chakravarthy, U., and Archer, D., Quantitative analysis of hyaluronan in vitreous humor using capillary electrophoresis, Electrophoresis, 15, 936–940 (1994).
371. Bothner, H., Waaler, T., and Wik, O., Limiting viscosity number and weight average molecular weight of hyaluronate samples produced by heat degradation, Int. J. Biol. Macromol., 10, 287–291 (1988).
372. Kachmar, J. F., Proteins and amino acids, in Fundamentals of Clinical Chemistry, Tietz, N. W., Ed., W. B. Saunders, Philadelphia, PA, 1987, pp. 177–262.
373. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent, J. Biol. Chem., 193, 265–275 (1951).
374. Uden, P. C. and Lavoie, L. M., Laboratory evaluation of commercial hyaluronate sodium products, J. Equine Vet. Sci., 17, 123–125 (1997).
375. Swann, D. A., Studies on hyaluronic acid. II. The protein component(s) of rooster comb hyaluronic acid, Biochim. Biophys. Acta, 160, 96–105 (1968).
376. Murphy, D., Pennock, C. A., and London, K. J., Gas-liquid chromatographic measurement of glucosamine and galactosamine content of urinary glycosaminoglycans, Clin. Chim. Acta, 53, 145–152 (1974).
377. Balazs, E. A. and Sweeney, D. B., in Replacement of the Vitreous Body of Monkeys with Reconstituted Vitreous and Hyaluronic Acid. Modern Problems in Ophthalmology (Surgery of Retinal Vascular Diseases and Prophylactic Treatment of Retinal Detachment, Streiff, E. B., Ed., Karger, Basel, 1966, pp. 230–232.
378. Swann, D. A. and Constable, I. J., Vitreous structure. II. Role of hyaluronate, Invest. Ophthalmol., 11, 164–168 (1972).
379. Constable, I. J. and Swann, D. A., Biological vitreous substitutes, Arch. Ophthalmol., 88, 544–548 (1972).
380. Delinger, J. L. and Balazs, E. A., Replacement of the liquid vitreous with NaHA in monkeys. I. Short term evaluation, Exp. Eye Res., 31, 81–99 (1980).
381. Delinger, J. L., El-Mofty, A. A. M., and Balazs, E. A., Replacement of the liquid vitreous with NaHA in monkeys. II. Long term evaluation, Exp. Eye Res., 30, 101–117 (1980).
382. Balazs, E. A., Ultrapure hyaluronic acid and the use thereof, U.S. Patent 4,141,973, (1979).
383. McKnight, S. J., Giangiacomo, J., and Adelstein, E., Inflammatory response to viscoelastic materials, Ophthalmic Surg., 18, 804–806 (1987).
384. Theodossiadis, G., Vitreous inflammatory reaction. Vitreous inflammation in rabbits, induced by saline, air, or sodium salt of hyaluronic acid, Mod. Probl. Ophthalmol., 18, 265–270 (1977).
385. Cavaliere, S., Spampinato, D., Caruso, P., Dal Bello, A., Reibaldi, A., and Drago, F., Effect of hyaluronic acid fractions in the rabbit eye, Ann. Ophthalmol., 22, 429–431 (1990).
386. Peiffer, R. L., The rabbit as an alternate model for the intraocular testing of viscoelastic substances, Vet. Comp. Ophthalmol., 1, 83–86 (1991).
387. Shen, W.-Y., Constable, I. J., Celva, E., and Rakoczy, P. E., Inhibition of diclofenac formulated in hyaluronan on angiogenesis in vitro and its intraocular tolerance in the rabbit eye, Graefes Arch. Clin. Exp. Ophthalmol., 238, 273–282 (2000).
388. Skelnik, D. L. and Lindstrom, R. L., Non-primate vitreal replacement model, U.S. Patent 5,102,653 (1992).
389. Floren, I., Viscoelastic purity, J. Cataract Refract. Surg., 24, 145–146 (1998).
390. Wicken, A. J. and Knox, K. W., Lipoteichoic acids: a new class of bacterial antigen, Science, 187, 1161–1167 (1975).
391. Hogg, S. D. and Manning, J. E., Determination of Viridans streptococci surface lipoteichoic acid by enzyme linked immune sorbent assay, FEMS Microbiol. Lett., 58, 239–242 (1989).
392. Tadler, M. B., Tice, G., and Wos, S. M., Sandwich immunoassay for the detection of lipoteichoic acid, J. Clin. Lab. Anal., 3, 21–25 (1989).
393. Laurent, T. C., Dahl, I. M., Dahl, L. B., Engstrom-Laurent, A., Eriksson, S., Fraser, J. R., Granath, K. A., Laurent, C., Laurent, U. B., Lilja, K., The catabolic fate of hyaluronic acid, Connect. Tissue Res., 15, 33–41 (1986).
394. Allen, S., Fraser, J. R., Laurent, U. B., Reed, R. K., and Laurent, T. C., Turnover of hyaluronan in the rabbit pleural space, J. Appl. Physiol., 73, 1457–1460 (1992).
395. Fraser, J. R., Laurent, T. C., Engstrom-Laurent, A., and Laurent, U. G., Elimination of hyaluronic acid from the blood stream in the human, Clin. Exp. Pharmacol. Physiol., 11, 17–25 (1984).
396. Smedsrod, B., Cellular events in the uptake and degradation of hyaluronan, Adv. Drug Delivery Rev., 7, 265–278 (1991).
397. Fraser, J. R., Kimpton, W. G., Laurent, T. C., Cahill, R. N., and Vakakis, N., Uptake and degradation of hyaluronan in lymphatic tissue, Biochem. J., 256, 153–158 (1988).
398. Reed, R. K. and Laurent, U. B., Turnover of hyaluronan in the microcirculation, Am. Rev. Respir. Dis., 146, S37–S39 (1992).
399. Fraser, J. R., Laurent, T. C., Pertoft, H., and Baxter, E., Plasma clearance, tissue distribution, and metabolism of hyaluronic acid injected intravenously in the rabbit, Biochem. J., 200, 415–424 (1981).
400. Baxter, E., Fraser, J. R., and Harris, G. S., Fractionation and recovery of secretions of synovial cells synthesized in culture with radioactive precursors, Ann. Rheum. Dis., 32, 35–40 (1973).
401. Underhill, C. B. and Toole, B. P., Binding of hyaluronate to the surface of cultured cells, J. Cell Biol., 82, 475–484 (1979).
402. Wilzbach, K. E., Tritium-labeling by exposure of organic compounds to tritium gas, J. Am. Chem. Soc., 79, 1013 (1957).
403. Highsmith, S. and Chipman, D. M., Preparation of tritium-labeled hyaluronic acid oligomers and their use in enzyme studies, Anal. Biochem., 61, 557–566 (1974).
404. Hook, M., Riesenfeld, J., and Lindahl, U. N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans, Anal. Biochem., 119, 236–245 (1982).
405. Swann, D. A., Silver, F. H., Sotman, S. L., and Hermann, H., Measurements of reducing end groups on bovine vitreous-humour hyaluronic acid by reaction with 14C cyanide, Biochem. J., 207, 409–414 (1982).
406. Orlando, P., Binaglia, L., De Feo, A., Orlando, M., Trenta, R., and Trevisi, R., An improved method for hyaluronic acid radioiodination, J. Labelled Compounds Radiopharmaceut., 36, 855–859 (1995).
407. Gustafson, S., Bjorkman, T., and Westlin, J. E., Labelling of high molecular weight hyaluronan with 125I-tyrosine: studies in vitro and in vivo in the rat, Glycoconj J., 11, 608–613 (1994).
408. Westerberg, G., Bergstrom, M., Gustafson, S., Lindqvist, U., Sundin, A., and Langstrom, B., Labelling of polysaccharides using [11C]cyanogen bromide. In vivo and in vitro evaluation of 11C-hyaluronan uptake kinetics, Nucl. Med. Biol., 22, 251–256 (1995).
409. Orlando, M., De Sanctis, G., Giodano, C., Valle, G., La Bua, R., and Ghidoni, R., Tritium labeled hyaluronic acid derivative, J. Labelled Compounds Radiopharmaceut., 22, 961–969 (1985).
410. Lindqvist, U., Westerberg, G., Bergstrom, M., Torsteindottir, I., Gustafson, S., Sundin, A., Loof, L., and Langstrom, B., [11C]Hyaluronan uptake with positron emission tomography in liver disease, Eur. J. Clin. Invest., 30, 600–607 (2000).
411. Beaty, N. B., Tew, W. P., and Mello, R. J., Relative molecular weight and concentration determination of sodium hyaluronate solutions by gel-exclusion high-performance liquid chromatography. Anal. Biochem., 147, 387–395 (1985).
412. Balazs, E. A., in Healon (Sodium Hyaluronate), A Guide to Its Use in Ophthalmic Surgery, Miller, D. and Stegmann, R., Eds., Wiley, New York, 1983, pp. 5–27.
413. Diamond, M. P., Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group, Fertil. Steril., 66, 904–910 (1996).
414. Johns, D. B., Keyport, G. M., Hoehler, F., and diZerega, G. S., Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery, Fertil. Steril., 76, 595–604 (2001).
415. Lussier, A., Cividino, A. A., McFarlane, C. A., Olszynski, W. P., Potashner, W. J., and De Medicis, R., Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada, J. Rheumatol., 23, 1579–1585 (1996).
416. Maheu, E., Ayral, X., and Dougados, M., A hyaluronan preparation (500- 730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan, Int. J. Clin. Pract., 56, 804–813 (2002).
417. Lohmander, L. S., Dalen, N., Englund, G., Hamalainen, M., Jensen, E. M., Karlsson, K., Odensten, M., Ryd, L., Sernbo, I., Suomalainen, O., and Tegnander, A., Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled multicentre trial, Ann. Rheum. Dis., 55, 424–431 (1996).
418. Namiki, O., Toyoshima, H., and Morisaki, N., Therapeutic effect of intraarticular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee, Int. J. Clin. Pharmacol. Ther. Toxicol., 20, 501–507 (1982).
419. Reed, R. K. and Laurent, U. B., Turnover of hyaluronan in the microcirculation, Am. Rev. Respir. Dis., 146, S37–S39 (1992).
420. Reed, R. K., Lilja, K., and Laurent, T. C., Hyaluronan in the rat with special reference to the skin, Acta Physiol. Scand., 134, 405–411 (1988).
421. Laurent, T. C., in Chemistry and Molecular Biology of the Intercellular Matrix, Balazs, E. A., Ed., Academic Press, London, 1970, pp. 703–732.
422. Laurent, T. C., Dahl, I. M., Dahl, L. B., Engstrom-Laurent, A., Eriksson, S., Fraser, J. R., Granath, K. A., Laurent, C., Laurent, U. B., Lilja, K., The catabolic fate of hyaluronic acid, Connect. Tissue Res., 15, 33–41 (1986).
423. Fraser, J. R., Kimpton, W. G., Laurent, T. C., Cahill, R. N., and Vakakis, N., Uptake and degradation of hyaluronan in lymphatic tissue, Biochem. J., 256, 153–158 (1988).
424. Smedsrod, B., Cellular events in the uptake and degradation of hyaluronan, Adv. Drug Delivery Rev., 7, 265–278 (1991).
425. Laurent, U. B., Dahl, L. B., and Reed, R. K., Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver, Exp. Physiol., 76, 695–703 (1991).
426. Tammi, R. H., Tammi, M. I., Hascall, V. C., Hogg, M., Pasonen, S., and MacCallum, D. K., A preformed basal lamina alters the metabolism and distribution of hyaluronan in epidermal keratinocyte “organotypic” cultures grown on collagen matrices, Histochem. Cell Biol., 113, 265–277 (2000).
427. Tammi, R., MacCallum, D., Hascall, V. C., Pienimaki, J. P., Hyttinen, M., and Tammi, M., Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides, J. Biol. Chem., 273, 28878–28888 (1998).
428. Tammi, R., Saamanen, A. M., Maibach, H. I., and Tammi, M., Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture, J. Invest. Dermatol., 97, 126–130 (1991).
429. Tammi, R. H., Pasonen-Seppanen, S., Kultti, A., Hyttinen, J. M. T., MacCallum, D. K., Hascall, V. C., and Tammi, M. I., Hyaluronan degradation in epidermis, Poster 30, Hyaluronan 2003 Conference, Cleveland, OH, 2003.
430. Stair-Nawy, S., Csoka, A. B., and Stern, R., Hyaluronidase expression in human skin fibroblasts, Biochem. Biophys. Res. Commun., 266, 268–273 (1999).
431. Reed, R. K., Laurent, U. B., Fraser, J. R., and Laurent, T. C., Removal rate of [3H]hyaluronan injected subcutaneously in rabbits, Am. J. Physiol., 259, H532–H535 (1990).
432. Fraser, J. R. and Laurent, T. C., Turnover and metabolism of hyaluronan, Ciba Found. Symp., 143, 41–45 (1989).
433. Arbogast, B., Hopwood, J. J., and Dorfman, A., Absence of hyaluronidase in cultured human skin fibroblasts, Biochem. Biophys. Res. Commun., 67, 376–382 (1975).
434. Roden, L., Campbell, P., Fraser, J. R., Laurent, T. C., Pertoft, H., and Thompson, J. N., Enzymic pathways of hyaluronan catabolism, Ciba Found. Symp., 143, 60–67 (1989).
435. Fraser, J. R., Laurent, T. C., Engstrom-Laurent, A., and Laurent, U. G., Elimination of hyaluronic acid from the blood stream in the human, Clin. Exp. Pharmacol. Physiol., 11, 17–25 (1984).
436. Floren, I., Viscoelastic purity, J. Cataract Refract. Surg., 24, 145–146 (1998).
437. Dick, H. B., Augustin, A. J., Pakula, T., and Pfeiffer, N., Endotoxins in ophthalmic viscosurgical devices, Eur. J. Ophthalmol., 13, 176–184 (2003).
438. Folk, J. C., Packer, A. J., Weingeist, T. A., and Howcroft, M. J., Sodium hyaluronate (Healon) in closed vitrectomy, Ophthal. Surg., 17, 299–306 (1986).
439. Vatne, H. O. and Syrdalen, P., The use of sodium hyaluronate (Healon) in the treatment of complicated cases of retinal detachment, Acta Ophthalmol. (Copenh.), 64, 169–172 (1986).
440. Jones, A., Regan, M., Ledingham, J., Pattrick, M., Manhire, A., and Doherty, M., Importance of placement of intra-articular steroid injections, Br. Med. J., 307, 1329–1330 (1993).
441. Goldberg, D. L., Brandt, K. D., and Cohen, A. S., Rapid, simple detection of trace amounts of synovial fluid, Arthritis Rheum., 16, 487–490 (1973).
442. Hamburger, M. I., Lakhanpal, S., Mooar, P. A., and Oster, D., Intra-articular hyaluronans: a review of product-specific safety profiles, Semin. Arthritis Rheum., 32, 296–309 (2003).
443. Bucher, W., Otto, T., and Hamburger, M. I., Differentiation of hyaluronate products by qualitative differences in their immunogenicity in rabbits: possible mechanism for product-specific severe adverse reactions? Comment on the article by Martens, Arthritis Rheum., 46, 2538–2548 (2002).
444. Ali, Y., Weinstein, M., and Jokl, P., Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid, Am. J. Med., 107, 641–642 (1999).
445. Yacyshyn, E. A. and Matteson, E. L., Gout after intra-articular injection of Hylan GF-20 (Synvisc), J. Rheumatol., 26, 2717 (1999).
446. Kroesen, S., Schmid, W., and Theiler, R., Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of Hylan G-F 20 (Synvisc), Clin. Rheumatol., 19, 147–149 (2000).
447. Luzar, M. J. and Altawil, B., Pseudogout following intraarticular injection of sodium hyaluronate, Arthritis Rheum., 41, 939–940 (1998).
448. Maillefert J. F., Hirschhorn, P., Pascaud F., Piroth C., and Tavernier C., Acute attack of chondrocalcinosis after an intraarticular injection of hyaluronan, Rev. Rhum. Engl. Ed., 64, 593–594 (1997).
449. Puttick, M. P. E., Wade, J. P., Chalmers, A., Connell, D. G., and Rangno, K. K., Acute local reactions after intra-articular Hylan for osteoarthritis of the knee, J. Rheumatol., 22, 1311–1314 (1995).
450. Allen, E. and Krohn, K., Adverse reaction to Hylan GF-20, J. Rheumatol., 27, 1572 (2000).
451. Martens, P. B., Bilateral symmetric inflammatory reaction to Hylan G-F 20 injection, Arthritis Rheum., 44, 978–979 (2001).
452. Rees, J. D. and Wojtulewski, J. A., Systemic reaction to viscosupplementation for knee osteoarthritis, Rheumatology, 40, 1425–1426 (2001).
453. Leopold, S. S., Warme, W. J., Pettis, P. D., and Shott, S., Increased frequency of acute local reaction to intra-articular Hylan GF-20 (Synvisc) in patients receiving more than one course of treatment, J. Bone Joint Surg., 84A, 1619–1623 (2002).
454. Pullman-Mooar, S., Mooar, P., Sieck, M., Clayburne, G., and Schumacher, H. R., Are there distinctive inflammatory flares after Hylan G-F 20 intraarticular injections?, J. Rheumatol., 29, 2611–2614 (2002).
455. Zardawi, I. M. and Chan, I., Synvisc perisynovitis, Pathology, 33, 519–520 (2001).
456. Chen, A. L., Desai, P., Adler, E. M., and DiCesare, P. E., Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases, J. Bone Joint Surg., 84A, 1142–1147 (2002).
457. Mont, M. and Etienne, G., Sequelae of Hylan G-F 20 viscosupplementation of the knee, J. Bone Joint Surg. Am., 85A, 967–968 (2003).
458. Morton, A. and Shannon, P., Increased frequency of acute local reaction to intraarticular Hylan G-F 20 (Synvisc) in patients receiving more than one course of treatment, J. Bone Joint Surg., 85-A, 2050 (2003).
459. Sasaki, M., Miyazaki, Y., and Takahashi, T., Hylan g-f 20 induces delayed foreign body inflammation in guinea pigs and rabbits, Toxicol. Pathol., 31, 321–325 (2003).
460. Beck, D. E., Cohen, Z., Fleshman, J. W., Kaufman, H. S., van Goor, H., and Wolff, B. G., A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine, Dis. Colon Rectum., 46, 1310–1319 (2003).
461. Tzianabos, A. O., Cisneros, R. L., Gershkovich, J., Johnson, J., Miller, R. J., Burns, J. W., and Onderdonk, A. B., Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection, Arch. Surg., 134, 1254–1259 (1999).
462. Neilands, J. B., Siderophores: structure and function of microbial iron transport compounds, J. Biol. Chem., 270, 26723–26726 (1995).
463. Biosca, E. G., Fouz, B., Alcaide, E., and Amaro, C., Siderophore-mediated iron acquisition mechanisms in Vibrio vulnificus biotype 2, Appl. Environ. Microbiol., 62, 928–935 (1996).
464. Ruiz-Perez, B., Cisneros, R. L., Matsumoto, T., Miller, R. J., Vasios, G., Calias, P., and Onderdonk, A. B., Protection against lethal intra-abdominal sepsis by 1-(3-dimethylaminopropyl)-3-ethylurea, J. Infect. Dis., 188, 378–387 (2003).
465. Ruiz-Perez, B., Cisneros, R. L., Matsumoto, T., Miller, R. J., Vasios, G., Calias, P., Onderdonk, A. B., Tzianabos, A. O., Gershkovich, J., Johnson, J., Burns, J. W., and Stavesk, M., Therapeutic utility of chemically modified hyaluronan, Poster 62, Hyaluronan 2003 Conference, Cleveland, OH (2003).
466. Matsumoto, T., Nieuwenhuis, E. E., Cisneros, R. L., Ruiz-Perez, B., Yamaguchi, K., Blumberg, R. S., and Onderdonk, A. B., Protective effect of ethyl-3-(3- dimethyl aminopropyl)urea dihydrochloride (EDU) against LPS-induced death in mice, J. Med. Microbiol., 53, 97–102 (2004).
467. Narins, R. S., Brandt, F., Leyden, J., Lorenc, Z. P., Rubin, M., and Smith, S. A., A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds, Dermatol. Surg., 29, 588–595 (2003).
468. Lupton, J. R. and Alster, T. S., Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel, Dermatol. Surg., 26, 135–137 (2000).
469. Raulin, C., Greve, B., Hartschuh, W., and Soegding, K., Exudative granulomatous reaction to hyaluronic acid (Hylaform), Contact Dermatitis, 43, 178–179 (2000).
470. Castrow, F. F. N. and Krull, E. A., Injectable collagen implant — update, J. Am. Acad. Dermatol., 9, 889–893 (1983).
471. Fernández-Aceñero, M. J., Zamora, E., and Borbujo, J., Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation, Dermatol. Surg., 29, 1225–1226 (2003).
472. Micheels, P., Human anti-hyaluronic acid antibodies: is it possible?, Dermatol. Surg., 27, 185–191 (2001).
473. Kavouni, A. and Stanec, J. J., Human antihyaluronic acid antibodies, Dermatol. Surg., 28, 359–360 (2002).
474. Friedman, P. M., Mafong, E. A., Kauvar, A. N. B., and Geronemus, R. G., Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation, Dermatol. Surg., 28, 491–494 (2002).
475. Lowe, N. J., Maxwell, C. A., Lowe, P., Duick, M. G., and Shah, K., Hyaluronic acid skin fillers: adverse reactions and skin testing, J. Am. Acad. Dermatol., 45, 930–933 (2001).
476. Lang, E., Mark, D., Miller, F. A., Miller, D., and Wik, O., Shear flow characteristics of sodium hyaluronate. Relationship to performance in anterior segment surgery, Arch. Ophthalmol., 102, 1079–1082 (1984).
477. Bothner, H. and Wik, O., Rheology of hyaluronate, Acta Otolaryngol. Suppl., 442, 25–30 (1987).
478. Dick, H. B., Krummenauer, F., Augustin, A. J., Pakula, T., and Pfeiffer, N., Healon5 viscoadaptive formulation: comparison to Healon and Healon GV, J. Cataract. Refract. Surg., 27, 320–326 (2001).
479. Hammer, M. E. and Burch, T. G., Viscous corneal protection by sodium hyaluronate, chondroitin sulfate, and methylcellulose, Invest. Ophthalmol. Vis. Sci., 25, 1329–1332 (1984).
480. Glasser, D. B., Matsuda, M., and Edelhauser, H. F., A comparison of the efficacy and toxicity of and intraocular pressure response to viscous solutions in the anterior chamber, Arch. Opththalmol., 104, 1819–1824 (1986).
481. Glasser, D. B., Katz, H. R., Boyd, J. E., Langdon, J. D., Shobe, S. L., and Peiffer, R. L., Protective effects of viscous solutions in phacoemulsification and traumatic lens implantation, Arch. Opththalmol., 107, 1047–1051 (1989).
482. McDermott, M. L., Hazlett, L. D., Barrett, R. P., and Lambert, R. J., Viscoelastic adherence to corneal endothelium following phacoemulsification, J. Cataract Refract. Surg., 24, 678–683 (1998).
483. Schubert, H. D., Denlinger, J. L., and Balazs, E. A., Exogenous Na-hyaluronate in the anterior chamber of the owl monkey and its effect on the intraocular pressure, Exp. Eye Res., 39, 137–152 (1984).
484. Fry, L. L., Postoperative intraocular pressure rises: a comparison of Healon, Amvisc, and Viscoat, J. Cataract Surg., 15, 415–420 (1989).
485. Mac Rae, S. M., Edelhauser, H. F., Hyndiuk, R. A., Burd, E. M., and Schultz, R. O., The effects of sodium hyaluronate, chondroitin sulfate, and methylcellulose on the corneal endotheliam and intraocular pressure, Am. J. Ophthalmol., 95, 332–341 (1983).
486. Dick, H. B., Augustin, A. J., and Pfeiffer, N., Osmolality of various viscoelastic substances: comparative study, J. Cataract Refract. Surg., 26, 1242–1246 (2000).
487. Poyer, J. F., Chan, K. Y., and Arshinoff, S. A., Quantitative method to determine the cohesion of viscoelastic agents by dynamic aspiration, J. Cataract Refract. Surg., 24, 1130–1135 (1998).
488. Poyer, J. F., Chan, K. Y., and Arshinoff, S. A., New method to measure the retention of viscoelastic agents on a rabbit corneal endothelial cell line after irrigation and aspiration, J. Cataract Refract. Surg., 24, 84–90 (1998).
489. Arshinoff, S. A., Dispersive and cohesive viscoelastic materials in phacoemulsification revisited 1998, Ophthal. Pract., 16, 24–32 (1998).
490. Arshinoff, S. A. and Wong, E., Understanding, retaining, and removing dispersive and pseudodispersive ophthalmic viscosurgical devices, J. Cataract Refract. Surg., 29, 2318–2323 (2003).
491. Hutz, W. W., Eckhardt, H. B., and Kohnen, T., Comparison of viscoelastic substances used on phacoemulsification, J. Cataract Refract. Surg., 22, 955–959 (1996).
492. Arshinoff, S. A., Dispersive-cohesive viscoelastic soft shell technique, J. Cataract Refract. Surg., 25, 167–173 (1999).
493. Miyata, K., Nagamoto, T., Maruoka, S., Tanabe, T., Nakahara, M., and Amano, S., Efficacy and safety of the soft-shell technique in cases with a hard lens nucleus, J. Cataract Refract. Surg., 28, 1546–1550 (2002).
494. Behndig, A. and Lundberg, B., Transient corneal edema after phacoemulsification: comparison of 3 viscoelastic regimens, J. Cataract Refract. Surg., 28, 1551–1556 (2002).
495. Arshinoff, S. A., Using BSS with viscoadaptives in the ultimate soft-shell technique, J. Cataract Refract Surg., 28, 1509–1514 (2002).
496. Zetterstrom, C., Wejde, G., and Taube, M., Healon5: comparison of 2 removal techniques, J. Cataract Refract. Surg., 28, 1561–1564 (2002).
497. Arshinoff, S. A., in Rock ‘n’ roll removal of Healon GV, 7th Annual National Ophthalmic Speakers Program, Medicopea, Quebec, 1997, pp. 29–30.
498. Tetz, M. R. and Holzer, M. P., Two-compartment technique to remove ophthalmic viscosurgical devices, J. Cataract Refract. Surg., 26, 641–643 (2000).
499. Assia, E. I., Apple, D. J., and Lim, E. S., Removal of viscoelastic materials after experimental cataract surgery in vitro, J. Cataract Refract. Surg., 18, 3–6 (1992).
500. Mamalis, N., OVDs viscosurgical, viscoelastic, and viscoadaptive. What does this mean? J. Cataract Refract. Surg., 28, 1497–1498 (2002).
501. Kiss B., Findl, O., Menapace, R., Petternel, V., Wirtitsch, M., Lorang, T., Gengler, M., and Drexler, W., Corneal endothelial cell protection with a dispersive viscoelastic material and an irrigating solution during phacoemulsification: lowcost versus expensive combination, J. Cataract Refract. Surg., 29, 733–740 (2003).
502. Soman, N. and Banerjee, R., Artificial vitreous replacement, Bio-Med. Mater. Eng., 13, 59–74 (2003).
503. Balazs, E. A. and Sweeney, D. B., in New and Controversial Aspects of Retinal Detachment, McPherson, A., Ed., Harper Row, New York, 1968, pp. 371–376.
504. Pruett, R. C., Schepens, C. L., and Swann, D. A., Hyaluronic acid vitreous substitute. A six-year clinical evaluation, Arch. Ophthalmol., 97, 2325–2330 (1979).
505. Buratto, L., Giardini, P., and Bellucci, R., in Viscoelastics in Ophthalmic Surgery, Slack Incorporated, Thorofare, NJ, 2000, pp. 313–351.
506. Wobig, M., Dickhut, A., Maier, R., and Vetter, G., Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee, Clin. Ther., 20, 410–423 (1998).
507. Brandt, K. D., Smith, G. N., and Simon, L. S., Author reply to Parenti, D., Murray, C.W., Treatment of intraarticular osteoarthritis of the knee with Hylan G-F 20: comment on the article by Brandt et al., Arthritis Rheum., 44, 1473–1476 (2001).
508. Altman, R. D. and Moskowitz, R., Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group, J. Rheumatol., 25, 2203–2212 (1998).
509. Felson, D. T. and Anderson, J. J., Hyaluronate sodium injections for osteoarthritis: hope, hype, and hard truths, Arch. Intern. Med., 162, 245–247 (2002).
510. Lo, G., LaValley, M., McAlindon, T., and Felson, D., Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis, JAMA, 290, 3115–3121 (2003).
511. Puhl, W., Bernau, A., Greiling, H., Kopcke, W., Pforringer, W., and Steck, K. J., Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study, Osteoarthritis Cartilage, 1, 233–241 (1993).
512. Lohmander, L. S., Dalen, N., Englund, G., Hamalainen, M., Jensen, E. M., Karlsson, K., Odensten, M., Ryd, L., Sernbo, I., Suomalainen, O., and Tegnander, A., Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled multicentre trial, Ann. Rheum. Dis., 55, 424–431 (1996).
513. Brandt, K. D., Block, J. A., Michalski, J. P., Moreland, L. W., Caldwell, J. R., and Lavin, P. T., Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group, Clin Orthop., 385, 130–143 (2001).
514. Brandt, K. D., Smith, G. N. Jr., and Simon, L. S., Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?, Arthritis Rheum., 43, 1192–1203 (2000).
515. Lequesne, M., Indices of severity and disease activity for osteoarthritis, Semin. Arthritis Rheum., 20, 48–54 (1991).
516. Lequesne, M. G., The algofunctional indices for hip and knee osteoarthritis, J. Rheumatol., 24, 779–781 (1997).
517. Altman, R., Brandt, K., Hochberg, M., Moskowitz, R., Bellamy, N., Bloch, D. A., Buckwalter, J., Dougados, M., Ehrlich, G., Lequesne, M., Lohmander, S., Murphy, W. A., Jr., Rosario-Jansen, T., Schwartz, B., and Trippel, S., Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop, Osteoarthritis Cartilage, 4, 217–243 (1996).
518. Dahlberg, L., Lohmander, L. S., and Ryd, L., Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain: a one-year doubleblind, placebo-controlled study, Arthritis Rheum., 37, 521–528 (1994).
519. Creamer, P., Sharif, M., George, E., Meadows, K., Cushnaghan, J., Shinmei, M., and Dieppe, P., Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action, Osteoarthritis Cartilage, 2, 133–140 (1994).
520. Sala, S. F. and Miguel, R. E., Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short-term study, Eur. J. Rheumatol. Inflamm., 15, 33–38 (1995).
521. Carrabba, M., Paresce, E., Angelini, M., Re, K. A., Torchiana, E. E. M., and Perbellini, A., The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion, Eur. J. Rheumatol. Inflamm., 15, 25–31 (1995).
522. Pham, T., Le Henanff, A., Ravaud, P., Dieppe, P., Paolozzi, L., and Dougados, M., Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis, Ann. Rheum. Dis., 63, 1611–1617 (2004).
523. Jubb, R., Piva, S., Beinat, L., Dacre, I., and Gishen, P. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee, Int. J. Clin. Pract., 57, 467–474 (2003).
524. Felson, D. T., The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments, Arthritis Rheum., 44, 1477–1480 (2001).
525. Liang, M. H., Larson, M. G., Cullen, K. E., and Schwartz, J.A., Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research, Arthritis Rheum., 28, 542–547 (1985).
526. Scale, D., Wobig, M., and Wolpert, W., Viscosupplementation of osteoarthritic knees with Hylan: a treatment schedule study, Curr. Therapeut. Res., 55, 220–232 (1994).
527. Lo, G. H., Felson, D. T., and LaValley, M., Intra-articular hyaluronic acid for treatment of osteoarthritis of the knee [Letters], JAMA, 291, 1441–1442 (2004).
528. Moskowitz, R. and Altman, R. D., Intra-articular hyaluronic acid for treatment of osteoarthritis of the knee [Letters], JAMA, 291, 1440–1441 (2004).
529. Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., Lohmander, S., Leeb, B., Lequesne, M., Mazieres, B., Martin-Mola, E., Pavelka, K., Pendleton, A., Punzi, L., Serni, U., Swoboda, B., Verbruggen, G., Zimmerman- Gorska, I., and Dougados, M., EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), Ann. Rheum. Dis., 62, 1145–1155 (2003).
530. Balazs, E. A. and Denlinger, J. L., Viscosupplementation: a new concept in the treatment of osteoarthritis, J. Rheumatol. Suppl., 39, 3–9 (1993).
531. Kawcak, C. E., Frisbie, D. D., Trotter, G. W., McIlwraith, C. W., Gillette, S. M., Powers, B. E., and Walton, R. M., Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation, Am. J. Vet. Res., 58, 1132–1140 (1997).
532. Pozo, M. A., Balazs, E. A., and Belmonte, C., Reduction of sensory responses to passive movements of inflamed knee joints by Hylan, Exp. Brain Res., 116, 3–9 (1997).
533. Gomis, A., Pawlak, M., Balazs, E. A., Schmidt, R. F., and Belmonte, C., Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents, Arthritis Rheum., 50, 314–326 (2004).
534. Ghosh, P. and Guidolin, D., Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin. Arthritis Rheum., 32, 10–37 (2002).
535. Asari, A., Miyauchi, S., Matsuzaka, S., Ito, T., Kominami, E., and Uchiyama, Y., Molecular weight-dependent effects of hyaluronate on the arthritic synovium, Arch. Histol. Cytol., 61, 125–135 (1998).
536. Wobig, M., Bach, G., Beks, P., Dickhut, A., Runzheimer, J., Schwieger, G., Vetter, G., and Balazs, E. A., The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of Hylan G-F 20 and a lower-molecular-weight hyaluronan, Clin. Ther., 21, 1549–1562 (1999).
537. Allard, S. and O'Regan, M., The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of Hylan G-F 20 and a lower-molecular-weight hyaluronan, Clin. Ther., 22, 792–795 (2000).
538. Karlsson, J., Sjogren, L. S., and Lohmander, L. S., Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis, a controlled, randomized, double-blind, parallel-design multicentre study, Rheumatology, 41, 1240–1248 (2002).
539. Knudson, W., Casey, B., Nishida, Y., Eger, W., Kuettner, K. E., and Knudson, C. B., Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis, Arthritis Rheum., 43, 1165–1174 (2000).
540. Lindqvist, U., Tolmachev, V., Kairemo, K., Astrom, G., Jonsson, E., and Lundqvist, H., Elimination of stabilised hyaluronan from the knee joint in healthy men, Clin. Pharmacokinet., 41, 603–613 (2002).
541. Tulandi, T., Introduction — prevention of adhesion formation: the journey continues, Hum. Reprod. Update, 7, 545–546 (2001).
542. Adzick, N. S. and Longaker, M. T., Scarless fetal healing. Therapeutic implications, Ann. Surg., 215, 3–7 (1992).
543. Longaker, M. T., Chiu, E. S., Adzick, N. S., Stern, M., Harrison, M. R., and Stern, R., Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid, Ann. Surg., 213, 292–296 (1991).
544. Shimanuki, T., Nishimura, K., Montz, F. J., Nakamura, R. M., and diZerega, G. S., Localized prevention of postsurgical adhesion formation and reformation with oxidized regenerated cellulose, J. Biomed. Mater. Res., 21, 173–185 (1987).
545. Sawada, T., Tsukada, K., Hasegawa, K., Ohashi, Y., Udagawa, Y., and Gomel, V., Cross-linked hyaluronate hydrogel prevents adhesion formation and reformation in mouse uterine horn model, Hum. Reprod., 16, 353–356 (2001).
546. Urman, B., Gomel, V., and Jetha, N., Effect of hyaluronic acid on postoperative intraperitoneal adhesion formation in the rat model, Fertil. Steril., 56, 563–567 (1991).
547. Johns, A., Evidence-based prevention of post-operative adhesions, Hum. Reprod. Update, 7, 577–579 (2001).
548. Diamond, M. P., Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group, Fertil. Steril., 66, 904–910 (1996).
549. Beck, D. E., The role of Seprafilm bioresorbable membrane in adhesion prevention, Eur. J. Surg. Suppl., 577, 49–55 (1997).
550. Beck, D. E., Cohen, Z., Fleshman, J. W., Kaufman, H. S., van Goor, H., and Wolff, B. G., A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine, Dis. Colon Rectum., 46, 1310–1319 (2003).
551. Kudo, F. A., Nishibe, T., Miyazaki, K., Murashita, T., Nishibe, M., and Yasuda, K., Use of bioresorbable membrane to prevent postoperative small bowel obstruction in transabdominal aortic aneurysm surgery, Surg. Today, 34, 648–651 (2004).
552. Miller, R. S., Steward, D. L., Tami, T. A., Sillars, M. J., Seiden, A. M., Shete, M., Paskowski, C., and Welge, J., The clinical effects of hyaluronic acid ester nasal dressing (Merogel) on intranasal wound healing after functional endoscopic sinus surgery, Otolaryngol. Head Neck Surg., 128, 862–869 (2003).
553. Catalano, P. J. and Roffman, E. J., Evaluation of middle meatal stenting after minimally invasive sinus techniques (MIST), Otolaryngol. Head Neck Surg., 128, 875–881 (2003).
554. Gaskins, R. E., Scarring in endoscopic ethmoidectomy, Am. J. Rhinol., 8, 271–274 (1994).
555. Jacob, A., Faddis, B. T., and Chole, R. A., MeroGel hyaluronic acid sinonasal implants: osteogenic implications, Laryngoscope, 112, 37–42 (2002).
556. Martini, A., Morra, B., Aimoni, C., and Radice, M., Use of a hyaluronan-based biomembrane in the treatment of chronic cholesteatomatous otitis media, Am. J. Otol., 21, 468–473 (2000).
557. Li, G., Feghali, J. G., Dinces, E., McElveen, J., and van de Water, T. R., Evaluation of esterified hyaluronic acid as middle ear-packing material, Arch. Otolaryngol. Head Neck Surg., 127, 534–539 (2001).
558. Stenfors, L. E., Treatment of tympanic membrane perforations with hyaluronan in an open pilot study of unselected patients, Acta Otolaryngol. Suppl., 442, 81–87 (1987).
559. Stenfors, L. E., Repair of traumatically ruptured tympanic membrane using hyaluronan, Acta Otolaryngol. Suppl., 442, 88–91 (1987).
560. Stenfors, L. E., Repair of tympanic membrane perforations using hyaluronic acid: an alternative to myringoplasty, J. Laryngol. Otol., 103, 39–40 (1989).
561. Stenfors, L. E., Berghem, L., Bloom, G. D., Hellstrom, S., and Soderberg, O., Exogenous hyaluronic acid (Healon) accelerates the healing of experimental myringotomies, Auris Nasus Larynx, 12, S214–S215 (1985).
562. Diamond, M. P., Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group, Fertil. Steril., 69, 1067–1074 (1998).
563. Thornton, M. H., Johns, D. B., Campeau, J. D., Hoehler, F., and DiZerega, G. S., Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open-label pilot study, Hum. Reprod., 13, 1480–1485 (1998).
564. Johns, D. B., Keyport, G. M., Hoehler, F., and diZerega, G. S., Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery, Fertil. Steril., 76, 595–604 (2001).
565. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies, and intrauterine adhesions, Fertil. Steril., 49, 944–955 (1988).
566. Kimmelman, C. P., Edelstein, D. R., and Cheng, H. J., Sepragel sinus (Hylan B) as a postsurgical dressing for endoscopic sinus surgery, Otolaryngol. Head Neck Surg., 125, 603–608 (2001).
567. Haney, A. F., Hesla, J., Hurst, B. S., Kettel, L. M., Murphy, A. A., Rock, J. A., Rowe, G., and Schlaff, W. D., Expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC7+) in preventing adhesions, Fertil. Steril., 63, 1021–1026 (1995).
568. Haney, A. F. and Doty, E., A barrier composed of chemically cross-linked hyaluronic acid (Incert) reduces postoperative adhesion formation, Fertil. Steril., 70, 145–151 (1998).
569. Schlussel, R., Cystoscopic correction of reflux, Curr. Urol. Rep., 5, 127–131 (2004).
570. Puri, P., Chertin, B., Velayudham, M., Dass, L., and Colhoun, E., Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results, J. Urol., 170, 1541–1544 (2003).
571. Chertin, B. and Puri, P., Endoscopic management of vesicoureteral reflux: does it stand the test of time?, Eur. Urol. 42, 598–606 (2002).
572. Oswald, J., Riccabona, M., Lusuardi, L., Bartsch, G., and Radmayr, C., Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children, Urology, 60, 894–897 (2002).
573. Gertzman, A. A. and Sunwoo, M. H. A pilot study evaluating sodium hyaluronate as a carrier for freeze-dried demineralized bone powder, Cell Tissue Bank., 2, 87–94 (2001).
574. Prato, G. P., Rotundo, R., Magnani, C., Soranzo, C., Muzzi, L., and Cairo, F., An autologous cell hyaluronic acid graft technique for gingival augmentation: a case series, J. Periodontol., 74, 262–267 (2003).
575. Schultz, R. H., Wollen, T. H., Greene, N. D., Nathan, D., Brown, K. K., and Mozier, J. O., Remote administration of hyaluronic acid to mammals. USP 4,808,576 (1989).